Dennis Burton - Publications

Affiliations: 
Scripps Research Institute, La Jolla, La Jolla, CA, United States 
Area:
Immunology, Virology Biology, Molecular Biology

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Agostinetto R, Rossi M, Dawson J, Lim A, Simoneau MH, Boucher C, Valldorf B, Ross-Gillespie A, Jardine JG, Sok D, Burton DR, Hassell T, Broly H, Palinsky W, Dupraz P, et al. Rapid cGMP Manufacturing of COVID-19 monoclonal antibody using stable CHO cell pools. Biotechnology and Bioengineering. PMID 34796474 DOI: 10.1002/bit.27995  1
2021 van Schooten J, van Haaren MM, Li H, McCoy LE, Havenar-Daughton C, Cottrell CA, Burger JA, van der Woude P, Helgers LC, Tomris I, Labranche CC, Montefiori DC, Ward AB, Burton DR, Moore JP, et al. Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates. Plos Pathogens. 17: e1009736. PMID 34432859 DOI: 10.1371/journal.ppat.1009736  1
2021 Antanasijevic A, Sewall LM, Cottrell CA, Carnathan DG, Jimenez LE, Ngo JT, Silverman JB, Groschel B, Georgeson E, Bhiman J, Bastidas R, LaBranche C, Allen JD, Copps J, Perrett HR, ... ... Burton DR, et al. Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM. Nature Communications. 12: 4817. PMID 34376662 DOI: 10.1038/s41467-021-25087-4  1
2021 Turner HL, Andrabi R, Cottrell CA, Richey ST, Song G, Callaghan S, Anzanello F, Moyer TJ, Abraham W, Melo M, Silva M, Scaringi N, Rakasz EG, Sattentau QJ, Irvine DJ, ... Burton DR, et al. Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization. Science Advances. 7. PMID 34321200 DOI: 10.1126/sciadv.abh2791  1
2021 Anand SP, Ding S, Tolbert WD, Prévost J, Richard J, Gil HM, Gendron-Lepage G, Cheung WF, Wang H, Pastora R, Saxena H, Wakarchuk W, Medjahed H, Wines BD, Hogarth PM, ... ... Burton DR, et al. Enhanced ability of plant-derived PGT121 glycovariants to eliminate HIV-1-infected cells. Journal of Virology. JVI0079621. PMID 34232070 DOI: 10.1128/JVI.00796-21  1
2021 Rissanen I, Krumm SA, Stass R, Whitaker A, Voss JE, Bruce EA, Rothenberger S, Kunz S, Burton DR, Huiskonen JT, Botten JW, Bowden TA, Doores KJ. Structural Basis for a Neutralizing Antibody Response Elicited by a Recombinant Hantaan Virus Gn Immunogen. Mbio. e0253120. PMID 34225492 DOI: 10.1128/mBio.02531-20  1
2021 Allen JD, Chawla H, Samsudin F, Zuzic L, Shivgan AT, Watanabe Y, He WT, Callaghan S, Song G, Yong P, Brouwer PJM, Song Y, Cai Y, Duyvesteyn HME, Malinauskas T, ... ... Burton DR, et al. Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation. Biochemistry. PMID 34213308 DOI: 10.1021/acs.biochem.1c00279  1
2021 Huang D, Tran JT, Peng L, Yang L, Suhandynata RT, Hoffman MA, Zhao F, Song G, He WT, Limbo O, Callaghan S, Landais E, Andrabi R, Sok D, Jardine JG, ... Burton DR, et al. A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs. Journal of Immunology (Baltimore, Md. : 1950). PMID 34183368 DOI: 10.4049/jimmunol.2100155  1
2021 Sahoo D, Katkar GD, Khandelwal S, Behroozikhah M, Claire A, Castillo V, Tindle C, Fuller M, Taheri S, Rogers TF, Beutler N, Ramirez SI, Rawlings SA, Pretorius V, Smith DM, ... Burton DR, et al. AI-guided discovery of the invariant host response to viral pandemics. Ebiomedicine. 103390. PMID 34127431 DOI: 10.1016/j.ebiom.2021.103390  1
2021 Bakowski MA, Beutler N, Wolff KC, Kirkpatrick MG, Chen E, Nguyen TH, Riva L, Shaabani N, Parren M, Ricketts J, Gupta AK, Pan K, Kuo P, Fuller M, Garcia E, ... ... Burton DR, et al. Drug repurposing screens identify chemical entities for the development of COVID-19 interventions. Nature Communications. 12: 3309. PMID 34083527 DOI: 10.1038/s41467-021-23328-0  1
2021 Yuan M, Huang D, Lee CD, Wu NC, Jackson AM, Zhu X, Liu H, Peng L, van Gils MJ, Sanders RW, Burton DR, Reincke SM, Prüss H, Kreye J, Nemazee D, et al. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Science (New York, N.Y.). PMID 34016740 DOI: 10.1126/science.abh1139  1
2021 Song G, He WT, Callaghan S, Anzanello F, Huang D, Ricketts J, Torres JL, Beutler N, Peng L, Vargas S, Cassell J, Parren M, Yang L, Ignacio C, Smith DM, ... ... Burton DR, et al. Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection. Nature Communications. 12: 2938. PMID 34011939 DOI: 10.1038/s41467-021-23074-3  1
2021 Zhou X, Ma F, Xie J, Yuan M, Li Y, Shaabani N, Zhao F, Huang D, Wu NC, Lee CD, Liu H, Li J, Chen Z, Hong Y, Liu WH, ... ... Burton DR, et al. Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2. Cell Reports. 109109. PMID 33932326 DOI: 10.1016/j.celrep.2021.109109  1
2021 Liu H, Yuan M, Huang D, Bangaru S, Zhao F, Lee CD, Peng L, Barman S, Zhu X, Nemazee D, Burton DR, van Gils MJ, Sanders RW, Kornau HC, Reincke SM, et al. A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection. Cell Host & Microbe. PMID 33894127 DOI: 10.1016/j.chom.2021.04.005  1
2021 Zhou P, Yuan M, Song G, Beutler N, Shaabani N, Huang D, He WT, Zhu X, Callaghan S, Yong P, Anzanello F, Peng L, Ricketts J, Parren M, Garcia E, ... ... Burton DR, et al. A protective broadly cross-reactive human antibody defines a conserved site of vulnerability on beta-coronavirus spikes. Biorxiv : the Preprint Server For Biology. PMID 33821273 DOI: 10.1101/2021.03.30.437769  1
2021 Allen JD, Chawla H, Samsudin F, Zuzic L, Shivgan AT, Watanabe Y, He WT, Callaghan S, Song G, Yong P, Brouwer PJM, Song Y, Cai Y, Duyvesteyn HME, Malinauskas T, ... ... Burton DR, et al. Site-specific steric control of SARS-CoV-2 spike glycosylation. Biorxiv : the Preprint Server For Biology. PMID 33758835 DOI: 10.1101/2021.03.08.433764  1
2021 Hangartner L, Beauparlant D, Rakasz E, Nedellec R, Hozé N, McKenney K, Martins MA, Seabright GE, Allen JD, Weiler AM, Friedrich TC, Regoes RR, Crispin M, Burton DR. Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primates. Science Translational Medicine. 13. PMID 33731434 DOI: 10.1126/scitranslmed.abe3349  1
2021 Conti S, Kaczorowski KJ, Song G, Porter K, Andrabi R, Burton DR, Chakraborty AK, Karplus M. Design of immunogens to elicit broadly neutralizing antibodies against HIV targeting the CD4 binding site. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33637649 DOI: 10.1073/pnas.2018338118  1
2021 Turner HL, Andrabi R, Cottrell CA, Richey ST, Song G, Callaghan S, Anzanello F, Moyer TJ, Abraham W, Melo M, Silva M, Scaringi N, Rakasz EG, Sattentau Q, Irvine DJ, ... Burton DR, et al. Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization. Biorxiv : the Preprint Server For Biology. PMID 33619491 DOI: 10.1101/2021.02.16.431310  1
2021 Yuan M, Huang D, Lee CD, Wu NC, Jackson AM, Zhu X, Liu H, Peng L, van Gils MJ, Sanders RW, Burton DR, Reincke SM, Prüss H, Kreye J, Nemazee D, et al. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Biorxiv : the Preprint Server For Biology. PMID 33619487 DOI: 10.1101/2021.02.16.430500  1
2021 Turman JM, Cheplowitz AM, Tiwari C, Thomas T, Joshi D, Bhat M, Wu Q, Pong E, Chu SY, Szymkowski DE, Sharma A, Seveau S, Robinson JM, Kwiek JJ, Burton D, et al. Accelerated Clearance and Degradation of Cell-Free HIV by Neutralizing Antibodies Occurs via FcγRIIb on Liver Sinusoidal Endothelial Cells by Endocytosis. Journal of Immunology (Baltimore, Md. : 1950). PMID 33568400 DOI: 10.4049/jimmunol.2000772  1
2021 Burton DR, Topol EJ. Variant-proof vaccines - invest now for the next pandemic. Nature. PMID 33558746 DOI: 10.1038/d41586-021-00340-4  1
2021 Burton DR. A new lease on life for an HIV-neutralizing antibody class and vaccine target. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33504595 DOI: 10.1073/pnas.2026390118  0.01
2021 Rappazzo CG, Tse LV, Kaku CI, Wrapp D, Sakharkar M, Huang D, Deveau LM, Yockachonis TJ, Herbert AS, Battles MB, O'Brien CM, Brown ME, Geoghegan JC, Belk J, Peng L, ... ... Burton DR, et al. Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science (New York, N.Y.). PMID 33495307 DOI: 10.1126/science.abf4830  1
2020 Huang D, Tran JT, Olson A, Vollbrecht T, Tenuta M, Guryleva MV, Fuller RP, Schiffner T, Abadejos JR, Couvrette L, Blane TR, Saye K, Li W, Landais E, Gonzalez-Martin A, ... ... Burton DR, et al. Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells. Nature Communications. 11: 6360. PMID 33288767 DOI: 10.1038/s41467-020-20304-y  1
2020 Wu NC, Yuan M, Bangaru S, Huang D, Zhu X, Lee CD, Turner HL, Peng L, Yang L, Burton DR, Nemazee D, Ward AB, Wilson IA. A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody. Plos Pathogens. 16: e1009089. PMID 33275640 DOI: 10.1371/journal.ppat.1009089  1
2020 Burton DR, Topol EJ. Toward superhuman SARS-CoV-2 immunity? Nature Medicine. PMID 33257892 DOI: 10.1038/s41591-020-01180-x  1
2020 Sevvana M, Rogers TF, Miller AS, Long F, Klose T, Beutler N, Lai YC, Parren M, Walker LM, Buda G, Burton DR, Rossmann MG, Kuhn RJ. Structural Basis of Zika Virus Specific Neutralization in Subsequent Flavivirus Infections. Viruses. 12. PMID 33255202 DOI: 10.3390/v12121346  1
2020 Ben-Othman R, Cai B, Liu AC, Varankovich N, He D, Blimkie TM, Lee AH, Gill EE, Novotny M, Aevermann B, Drissler S, Shannon CP, McCann S, Marty K, Bjornson G, ... ... Burton DR, et al. Systems Biology Methods Applied to Blood and Tissue for a Comprehensive Analysis of Immune Response to Hepatitis B Vaccine in Adults. Frontiers in Immunology. 11: 580373. PMID 33250895 DOI: 10.3389/fimmu.2020.580373  1
2020 Rappazzo CG, Tse LV, Kaku CI, Wrapp D, Sakharkar M, Huang D, Deveau LM, Yockachonis TJ, Herbert AS, Battles MB, O'Brien CM, Brown ME, Geoghegan JC, Belk J, Peng L, ... ... Burton DR, et al. An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19. Biorxiv : the Preprint Server For Biology. PMID 33236009 DOI: 10.1101/2020.11.17.385500  1
2020 Huang D, Tran JT, Olson A, Vollbrecht T, Tenuta M, Guryleva MV, Fuller RP, Schiffner T, Abadejos JR, Couvrette L, Blane TR, Saye K, Li W, Landais E, Gonzalez-Martin A, ... ... Burton DR, et al. Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells. Nature Communications. 11: 5850. PMID 33203876 DOI: 10.1038/s41467-020-19650-8  1
2020 Martins MA, Gonzalez-Nieto L, Ricciardi MJ, Bailey VK, Dang CM, Bischof GF, Pedreño-Lopez N, Pauthner MG, Burton DR, Parks CL, Earl P, Moss B, Rakasz EG, Lifson JD, Desrosiers RC, et al. Rectal Acquisition of SIVmac239 Infection Despite Vaccine-Induced Immune Responses Against the Entire SIV Proteome. Journal of Virology. PMID 33028714 DOI: 10.1128/JVI.00979-20  1
2020 Sahoo D, Katkar GD, Khandelwal S, Behroozikhah M, Claire A, Castillo V, Tindle C, Fuller M, Taheri S, Rogers TF, Beutler N, Ramirez SI, Rawlings SA, Pretorius V, Smith DM, ... Burton DR, et al. AI-guided discovery of the invariant host response to viral pandemics. Biorxiv : the Preprint Server For Biology. PMID 32995790 DOI: 10.1101/2020.09.21.305698  1
2020 Song G, He WT, Callaghan S, Anzanello F, Huang D, Ricketts J, Torres JL, Beutler N, Peng L, Vargas S, Cassell J, Parren M, Yang L, Ignacio C, Smith DM, ... ... Burton DR, et al. Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection. Biorxiv : the Preprint Server For Biology. PMID 32995770 DOI: 10.1101/2020.09.22.308965  1
2020 Pedreño-Lopez N, Ricciardi MJ, Rosen BC, Song G, Andrabi R, Burton DR, Rakasz EG, Watkins DI. An Automated Fluorescence-Based Method to Isolate Bone Marrow-Derived Plasma Cells from Rhesus Macaques Using SIVmac239 SOSIP.664. Molecular Therapy. Methods & Clinical Development. 18: 781-790. PMID 32953929 DOI: 10.1016/J.Omtm.2020.08.004  1
2020 Zhao F, Joyce C, Burns A, Nogal B, Cottrell CA, Ramos A, Biddle T, Pauthner M, Nedellec R, Qureshi H, Mason R, Landais E, Briney B, Ward AB, Burton DR, et al. Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques. Cell Reports. 32: 108122. PMID 32905766 DOI: 10.1016/J.Celrep.2020.108122  1
2020 Cottrell CA, van Schooten J, Bowman CA, Yuan M, Oyen D, Shin M, Morpurgo R, van der Woude P, van Breemen M, Torres JL, Patel R, Gross J, Sewall LM, Copps J, Ozorowski G, ... ... Burton DR, et al. Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates. Plos Pathogens. 16: e1008753. PMID 32866207 DOI: 10.1371/Journal.Ppat.1008753  1
2020 Yuan M, Liu H, Wu NC, Lee CD, Zhu X, Zhao F, Huang D, Yu W, Hua Y, Tien H, Rogers TF, Landais E, Sok D, Jardine JG, Burton DR, et al. Structural basis of a shared antibody response to SARS-CoV-2. Science (New York, N.Y.). PMID 32661058 DOI: 10.1126/Science.Abd2321  1
2020 Carnathan DG, Kaushik K, Ellebedy AH, Enemuo CA, Gebru EH, Dhadvai P, Rasheed MAU, Pauthner MG, Ozorowski G, Ahmed R, Burton DR, Ward AB, Silvestri G, Crotty S, Locci M. Harnessing Activin A Adjuvanticity to Promote Antibody Responses to BG505 HIV Envelope Trimers. Frontiers in Immunology. 11: 1213. PMID 32612608 DOI: 10.3389/Fimmu.2020.01213  1
2020 Yuan M, Liu H, Wu NC, Lee CD, Zhu X, Zhao F, Huang D, Yu W, Hua Y, Tien H, Rogers TF, Landais E, Sok D, Jardine JG, Burton DR, et al. Structural basis of a public antibody response to SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 32577642 DOI: 10.1101/2020.06.08.141267  1
2020 Nogal B, McCoy LE, van Gils MJ, Cottrell CA, Voss JE, Andrabi R, Pauthner M, Liang CH, Messmer T, Nedellec R, Shin M, Turner HL, Ozorowski G, Sanders RW, Burton DR, et al. HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite. Science Advances. 6: eaba0512. PMID 32548265 DOI: 10.1126/Sciadv.Aba0512  1
2020 Rogers TF, Zhao F, Huang D, Beutler N, Burns A, He WT, Limbo O, Smith C, Song G, Woehl J, Yang L, Abbott RK, Callaghan S, Garcia E, Hurtado J, ... ... Burton DR, et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science (New York, N.Y.). PMID 32540903 DOI: 10.1126/Science.Abc7520  1
2020 Wec AZ, Wrapp D, Herbert AS, Maurer DP, Haslwanter D, Sakharkar M, Jangra RK, Dieterle ME, Lilov A, Huang D, Tse LV, Johnson NV, Hsieh CL, Wang N, Nett JH, ... ... Burton DR, et al. Broad neutralization of SARS-related viruses by human monoclonal antibodies. Science (New York, N.Y.). PMID 32540900 DOI: 10.1126/Science.Abc7424  1
2020 Stanfield RL, Berndsen ZT, Huang R, Sok D, Warner G, Torres JL, Burton DR, Ward AB, Wilson IA, Smider VV. Structural basis of broad HIV neutralization by a vaccine-induced cow antibody. Science Advances. 6: eaba0468. PMID 32518821 DOI: 10.1126/Sciadv.Aba0468  1
2020 Rogers TF, Zhao F, Huang D, Beutler N, Burns A, He WT, Limbo O, Smith C, Song G, Woehl J, Yang L, Abbott RK, Callaghan S, Garcia E, Hurtado J, ... ... Burton DR, et al. Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal model. Biorxiv : the Preprint Server For Biology. PMID 32511387 DOI: 10.1101/2020.05.11.088674  1
2020 Wec AZ, Wrapp D, Herbert AS, Maurer D, Haslwanter D, Sakharkar M, Jangra RK, Dieterle ME, Lilov A, Huang D, Tse LV, Johnson NV, Hsieh CL, Wang N, Nett JH, ... ... Burton DR, et al. Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein. Biorxiv : the Preprint Server For Biology. PMID 32511337 DOI: 10.1101/2020.05.15.096511  1
2020 Burton DR, Walker LM. Rational Vaccine Design in the Time of COVID-19. Cell Host & Microbe. 27: 695-698. PMID 32407707 DOI: 10.1016/j.chom.2020.04.022  1
2020 Moyer TJ, Kato Y, Abraham W, Chang JYH, Kulp DW, Watson N, Turner HL, Menis S, Abbott RK, Bhiman JN, Melo MB, Simon HA, Herrera-De la Mata S, Liang S, Seumois G, ... ... Burton DR, et al. Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunity. Nature Medicine. 26: 804. PMID 32405059 DOI: 10.1038/S41591-020-0861-0  1
2020 Nogal B, Bianchi M, Cottrell CA, Kirchdoerfer RN, Sewall LM, Turner HL, Zhao F, Sok D, Burton DR, Hangartner L, Ward AB. Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines. Cell Reports. 30: 3755-3765.e7. PMID 32187547 DOI: 10.1016/j.celrep.2020.02.061  1
2020 Pedreño-Lopez N, Dang CM, Rosen BC, Ricciardi MJ, Bailey VK, Gutman MJ, Gonzalez-Nieto L, Pauthner MG, Le K, Song G, Andrabi R, Weisgrau KL, Pomplun N, Martinez-Navio JM, Fuchs SP, ... ... Burton DR, et al. Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies. Molecular Therapy. Methods & Clinical Development. 16: 225-237. PMID 32083148 DOI: 10.1016/J.Omtm.2020.01.010  1
2020 Moyer TJ, Kato Y, Abraham W, Chang JYH, Kulp DW, Watson N, Turner HL, Menis S, Abbott RK, Bhiman JN, Melo MB, Simon HA, Herrera-De la Mata S, Liang S, Seumois G, ... ... Burton DR, et al. Engineered immunogen binding to alum adjuvant enhances humoral immunity. Nature Medicine. PMID 32066977 DOI: 10.1038/S41591-020-0753-3  1
2020 Joyce C, Burton DR, Briney B. Comparisons of the antibody repertoires of a humanized rodent and humans by high throughput sequencing. Scientific Reports. 10: 1120. PMID 31980672 DOI: 10.1038/S41598-020-57764-7  1
2020 Yang YR, McCoy LE, van Gils MJ, Andrabi R, Turner HL, Yuan M, Cottrell CA, Ozorowski G, Voss J, Pauthner M, Polveroni TM, Messmer T, Wilson IA, Sanders RW, Burton DR, et al. Autologous neutralizing antibody responses to an HIV envelope glycan hole are not easily broadened in rabbits. Journal of Virology. PMID 31941772 DOI: 10.1128/Jvi.01861-19  1
2020 Cirelli KM, Carnathan DG, Nogal B, Martin JT, Rodriguez OL, Upadhyay AA, Enemuo CA, Gebru EH, Choe Y, Viviano F, Nakao C, Pauthner MG, Reiss S, Cottrell CA, Smith ML, ... ... Burton DR, et al. Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance. Cell. 180: 206. PMID 31923396 DOI: 10.1016/j.cell.2019.12.027  1
2019 Zhang L, Irimia A, He L, Landais E, Rantalainen K, Leaman DP, Vollbrecht T, Stano A, Sands DI, Kim AS, Poignard P, Burton DR, Murrell B, Ward AB, et al. An MPER antibody neutralizes HIV-1 using germline features shared among donors. Nature Communications. 10: 5389. PMID 31772165 DOI: 10.1038/S41467-019-12973-1  1
2019 Havenar-Daughton C, Carnathan DG, Boopathy AV, Upadhyay AA, Murrell B, Reiss SM, Enemuo CA, Gebru EH, Choe Y, Dhadvai P, Viviano F, Kaushik K, Bhiman JN, Briney B, Burton DR, et al. Rapid Germinal Center and Antibody Responses in Non-human Primates after a Single Nanoparticle Vaccine Immunization. Cell Reports. 29: 1756-1766.e8. PMID 31722194 DOI: 10.1016/J.Celrep.2019.10.008  1
2019 Steichen JM, Lin YC, Havenar-Daughton C, Pecetta S, Ozorowski G, Willis JR, Toy L, Sok D, Liguori A, Kratochvil S, Torres JL, Kalyuzhniy O, Melzi E, Kulp DW, Raemisch S, ... ... Burton DR, et al. A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses. Science (New York, N.Y.). PMID 31672916 DOI: 10.1126/Science.Aax4380  1
2019 Haynes BF, Burton DR, Mascola JR. Multiple roles for HIV broadly neutralizing antibodies. Science Translational Medicine. 11. PMID 31666399 DOI: 10.1126/scitranslmed.aaz2686  1
2019 Pegu A, Borate B, Huang Y, Pauthner MG, Hessell AJ, Julg B, Doria-Rose NA, Schmidt SD, Carpp LN, Cully MD, Chen X, Shaw GM, Barouch DH, Haigwood NL, Corey L, ... Burton DR, et al. A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge. Cell Host & Microbe. 26: 336-346.e3. PMID 31513771 DOI: 10.1016/J.Chom.2019.08.014  1
2019 Burton DR. Antibody barriers to going viral. The Journal of Experimental Medicine. PMID 31444247 DOI: 10.1084/jem.20191099  0.01
2019 Umotoy J, Bagaya BS, Joyce C, Schiffner T, Menis S, Saye-Francisco KL, Biddle T, Mohan S, Vollbrecht T, Kalyuzhniy O, Madzorera S, Kitchin D, Lambson B, Nonyane M, Kilembe W, ... ... Burton DR, et al. Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan. Immunity. 51: 141-154.e6. PMID 31315032 DOI: 10.1016/J.Immuni.2019.06.004  1
2019 von Bredow B, Andrabi R, Grunst M, Grandea AG, Le K, Song G, Berndsen ZT, Porter K, Pallesen J, Ward AB, Burton DR, Evans DT. Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from Neutralization. Mbio. 10. PMID 31266872 DOI: 10.1128/mBio.01255-19  1
2019 Andrabi R, Pallesen J, Allen JD, Song G, Zhang J, de Val N, Gegg G, Porter K, Su CY, Pauthner M, Newman A, Bouton-Verville H, Garces F, Wilson IA, Crispin M, ... ... Burton DR, et al. The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template. Cell Reports. 27: 2426-2441.e6. PMID 31116986 DOI: 10.1016/J.Celrep.2019.04.082  1
2019 Khan SN, Sok D, Tran K, Movsesyan A, Dubrovskaya V, Burton DR, Wyatt RT. Correction for Khan et al., "Targeting the HIV-1 Spike and Coreceptor with Bi- and Trispecific Antibodies for Single-Component Broad Inhibition of Entry". Journal of Virology. 93. PMID 31092683 DOI: 10.1128/JVI.00391-19  1
2019 Cirelli KM, Carnathan DG, Nogal B, Martin JT, Rodriguez OL, Upadhyay AA, Enemuo CA, Gebru EH, Choe Y, Viviano F, Nakao C, Pauthner MG, Reiss S, Cottrell CA, Smith ML, ... ... Burton DR, et al. Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance. Cell. PMID 31080066 DOI: 10.1016/J.Cell.2019.04.012  1
2019 Seabright GE, Doores KJ, Burton DR, Crispin M. Protein and glycan mimicry in HIV vaccine design. Journal of Molecular Biology. PMID 31028779 DOI: 10.1016/j.jmb.2019.04.016  1
2019 Sok D, Burton DR. Publisher Correction: Recent progress in broadly neutralizing antibodies to HIV. Nature Immunology. PMID 30705417 DOI: 10.1038/s41590-019-0329-x  1
2019 Briney B, Inderbitzin A, Joyce C, Burton DR. Commonality despite exceptional diversity in the baseline human antibody repertoire. Nature. PMID 30664748 DOI: 10.1038/S41586-019-0879-Y  1
2019 Voss JE, Gonzalez-Martin A, Andrabi R, Fuller RP, Murrell B, McCoy LE, Porter K, Huang D, Li W, Sok D, Le K, Briney B, Chateau M, Rogers G, Hangartner L, ... ... Burton D, et al. Reprogramming the antigen specificity of B cells using genome-editing technologies. Elife. 8. PMID 30648968 DOI: 10.7554/Elife.42995  1
2018 Allen ER, Krumm SA, Raghwani J, Halldorsson S, Elliott A, Graham VA, Koudriakova E, Harlos K, Wright D, Warimwe GM, Brennan B, Huiskonen JT, Dowall SD, Elliott RM, Pybus OG, ... Burton DR, et al. A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus. Cell Reports. 25: 3750-3758.e4. PMID 30590046 DOI: 10.1016/j.celrep.2018.12.001  1
2018 Burton DR. Advancing an HIV vaccine; advancing vaccinology. Nature Reviews. Immunology. PMID 30560910 DOI: 10.1038/s41577-018-0103-6  0.01
2018 Pauthner MG, Nkolola JP, Havenar-Daughton C, Murrell B, Reiss SM, Bastidas R, Prévost J, Nedellec R, von Bredow B, Abbink P, Cottrell CA, Kulp DW, Tokatlian T, Nogal B, Bianchi M, ... ... Burton DR, et al. Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers. Immunity. PMID 30552025 DOI: 10.1016/J.Immuni.2018.11.011  1
2018 He L, Kumar S, Allen JD, Huang D, Lin X, Mann CJ, Saye-Francisco KL, Copps J, Sarkar A, Blizard GS, Ozorowski G, Sok D, Crispin M, Ward AB, Nemazee D, ... Burton DR, et al. HIV-1 vaccine design through minimizing envelope metastability. Science Advances. 4: eaau6769. PMID 30474059 DOI: 10.1126/Sciadv.Aau6769  1
2018 Sok D, Burton DR. Recent progress in broadly neutralizing antibodies to HIV. Nature Immunology. 19: 1179-1188. PMID 30333615 DOI: 10.1038/s41590-018-0235-7  1
2018 Cao L, Pauthner M, Andrabi R, Rantalainen K, Berndsen Z, Diedrich JK, Menis S, Sok D, Bastidas R, Park SR, Delahunty CM, He L, Guenaga J, Wyatt RT, Schief WR, ... ... Burton DR, et al. Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer. Nature Communications. 9: 3693. PMID 30209313 DOI: 10.1038/s41467-018-06121-4  1
2018 Bianchi M, Turner HL, Nogal B, Cottrell CA, Oyen D, Pauthner M, Bastidas R, Nedellec R, McCoy LE, Wilson IA, Burton DR, Ward AB, Hangartner L. Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization. Immunity. PMID 30097292 DOI: 10.1016/J.Immuni.2018.07.009  1
2018 Saphire EO, Schendel SL, Fusco ML, Gangavarapu K, Gunn BM, Wec AZ, Halfmann PJ, Brannan JM, Herbert AS, Qiu X, Wagh K, He S, Giorgi EE, Theiler J, Pommert KBJ, ... ... Burton DR, et al. Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection. Cell. 174: 938-952.e13. PMID 30096313 DOI: 10.1016/J.Cell.2018.07.033  0.01
2018 Khan SN, Sok D, Tran K, Movsesyan A, Dubrovskaya V, Burton D, Wyatt RT. Targeting the HIV-1 spike and co-receptor with bi- and trispecific antibodies for single-component broad inhibition of entry. Journal of Virology. PMID 29976677 DOI: 10.1128/JVI.00384-18  1
2018 Ali A, Ng HL, Blankson JN, Burton DR, Buckheit RW, Moldt B, Fulcher JA, Ibarrondo FJ, Anton PA, Yang OO. Highly Attenuated Infection with a Vpr-Deleted Molecular Clone of HIV-1. The Journal of Infectious Diseases. PMID 29878133 DOI: 10.1093/Infdis/Jiy346  1
2018 Martins MA, Tully DC, Pedreño-Lopez N, von Bredow B, Pauthner MG, Shin YC, Yuan M, Lima NS, Bean DJ, Gonzalez-Nieto L, Domingues A, Gutman MJ, Maxwell HS, Magnani DM, Ricciardi MJ, ... ... Burton DR, et al. + rhesus macaques vaccinated with , and manifest early control of SIVmac239 replication. Journal of Virology. PMID 29875239 DOI: 10.1128/Jvi.00690-18  1
2018 Andrabi R, Bhiman JN, Burton DR. Strategies for a multi-stage neutralizing antibody-based HIV vaccine. Current Opinion in Immunology. 53: 143-151. PMID 29775847 DOI: 10.1016/j.coi.2018.04.025  1
2018 Cao L, Diedrich JK, Ma Y, Wang N, Pauthner M, Park SR, Delahunty CM, McLellan JS, Burton DR, Yates JR, Paulson JC. Global site-specific analysis of glycoprotein N-glycan processing. Nature Protocols. 13: 1196-1212. PMID 29725121 DOI: 10.1038/Nprot.2018.024  1
2018 Magnani DM, Rogers TF, Maness NJ, Grubaugh ND, Beutler N, Bailey VK, Gonzalez-Nieto L, Gutman MJ, Pedreño-Lopez N, Kwal JM, Ricciardi MJ, Myers TA, Julander JG, Bohm RP, Gilbert MH, ... ... Burton DR, et al. Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques. Nature Communications. 9: 1624. PMID 29691387 DOI: 10.1038/S41467-018-04056-4  1
2018 Shivatare VS, Shivatare SS, Lee CD, Liang CH, Liao KS, Cheng YY, Saidachary G, Wu CY, Lin NH, Kwong PD, Burton DR, Wu CY, Wong CH. Unprecedented Role of Hybrid N-Glycans as Ligands for HIV-1 Broadly Neutralizing Antibodies. Journal of the American Chemical Society. PMID 29578688 DOI: 10.1021/Jacs.8B00896  1
2018 Zhou T, Zheng A, Baxa U, Chuang GY, Georgiev IS, Kong R, O'Dell S, Shahzad-Ul-Hussan S, Shen CH, Tsybovsky Y, Bailer RT, Gift SK, Louder MK, McKee K, Rawi R, ... ... Burton DR, et al. A Neutralizing Antibody Recognizing Primarily N-linked Glycan Targets the Silent Face of the HIV Envelope. Immunity. PMID 29548671 DOI: 10.1016/J.Immuni.2018.02.013  1
2018 Cheng HD, Grimm SK, Gilman MS, Gwom LC, Sok D, Sundling C, Donofrio G, Hedestam GBK, Bonsignori M, Haynes BF, Lahey TP, Maro I, von Reyn CF, Gorny MK, Zolla-Pazner S, ... ... Burton DR, et al. Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding site. Jci Insight. 3. PMID 29515029 DOI: 10.1172/Jci.Insight.97018  1
2018 Wagh K, Seaman MS, Zingg M, Fitzsimons T, Barouch DH, Burton DR, Connors M, Ho DD, Mascola JR, Nussenzweig MC, Ravetch J, Gautam R, Martin MA, Montefiori DC, Korber B. Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. Plos Pathogens. 14: e1006860. PMID 29505593 DOI: 10.1371/Journal.Ppat.1006860  1
2018 Voss JE, Andrabi R, McCoy LE, de Val N, Fuller RP, Messmer T, Su CY, Sok D, Khan SN, Garces F, Pritchard LK, Wyatt RT, Ward AB, Crispin M, Wilson IA, ... Burton DR, et al. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model. Cell Reports. 22: 1103. PMID 29386130 DOI: 10.1016/j.celrep.2017.10.089  1
2018 Walker LM, Burton DR. Passive immunotherapy of viral infections: 'super-antibodies' enter the fray. Nature Reviews. Immunology. PMID 29379211 DOI: 10.1038/nri.2017.148  1
2018 Teijaro JR, Burton DR. Taking down defenses to improve vaccines. Science (New York, N.Y.). 359: 277-278. PMID 29348225 DOI: 10.1126/Science.Aar5421  0.01
2017 Landais E, Murrell B, Briney B, Murrell S, Rantalainen K, Berndsen ZT, Ramos A, Wickramasinghe L, Smith ML, Eren K, de Val N, Wu M, Cappelletti A, Umotoy J, Lie Y, ... ... Burton DR, et al. HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage. Immunity. 47: 990-1003.e9. PMID 29166592 DOI: 10.1016/J.Immuni.2017.11.002  1
2017 Andrabi R, Su CY, Liang CH, Shivatare SS, Briney B, Voss JE, Nawazi SK, Wu CY, Wong CH, Burton DR. Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development. Immunity. 47: 1004. PMID 29166578 DOI: 10.1016/j.immuni.2017.10.012  1
2017 Kulp DW, Steichen JM, Pauthner M, Hu X, Schiffner T, Liguori A, Cottrell CA, Havenar-Daughton C, Ozorowski G, Georgeson E, Kalyuzhniy O, Willis JR, Kubitz M, Adachi Y, Reiss SM, ... ... Burton DR, et al. Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding. Nature Communications. 8: 1655. PMID 29162799 DOI: 10.1038/S41467-017-01549-6  1
2017 Magnani DM, Rogers TF, Beutler N, Ricciardi MJ, Bailey VK, Gonzalez-Nieto L, Briney B, Sok D, Le K, Strubel A, Gutman MJ, Pedreño-Lopez N, Grubaugh ND, Silveira CGT, Maxwell HS, ... ... Burton DR, et al. Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques. Science Translational Medicine. 9. PMID 28978754 DOI: 10.1126/Scitranslmed.Aan8184  1
2017 Voss JE, Andrabi R, McCoy LE, de Val N, Fuller RP, Messmer T, Su CY, Sok D, Khan SN, Garces F, Pritchard LK, Wyatt RT, Ward AB, Crispin M, Wilson IA, ... Burton DR, et al. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model. Cell Reports. 21: 222-235. PMID 28978475 DOI: 10.1016/J.Celrep.2017.09.024  1
2017 Julg B, Liu PT, Wagh K, Fischer WM, Abbink P, Mercado NB, Whitney JB, Nkolola JP, McMahan K, Tartaglia LJ, Borducchi EN, Khatiwada S, Kamath M, LeSuer JA, Seaman MS, ... ... Burton DR, et al. Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail. Science Translational Medicine. 9. PMID 28931655 DOI: 10.1126/Scitranslmed.Aao4235  1
2017 Xu L, Pegu A, Rao E, Doria-Rose N, Beninga J, McKee K, Lord DM, Wei RR, Deng G, Louder M, Schmidt SD, Mankoff Z, Wu L, Asokan M, Beil C, ... ... Burton DR, et al. Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques. Science (New York, N.Y.). PMID 28931639 DOI: 10.1126/Science.Aan8630  1
2017 Andrabi R, Su CY, Liang CH, Shivatare SS, Briney B, Voss JE, Nawazi SK, Wu CY, Wong CH, Burton DR. Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development. Immunity. PMID 28916265 DOI: 10.1016/J.Immuni.2017.08.006  1
2017 He L, Lin X, de Val N, Saye-Francisco KL, Mann CJ, Augst R, Morris CD, Azadnia P, Zhou B, Sok D, Ozorowski G, Ward AB, Burton DR, Zhu J. Hidden Lineage Complexity of Glycan-Dependent HIV-1 Broadly Neutralizing Antibodies Uncovered by Digital Panning and Native-Like gp140 Trimer. Frontiers in Immunology. 8: 1025. PMID 28883821 DOI: 10.3389/Fimmu.2017.01025  1
2017 Magnani DM, Silveira CGT, Ricciardi MJ, Gonzalez-Nieto L, Pedreño-Lopez N, Bailey VK, Gutman MJ, Maxwell HS, Domingues A, Costa PR, Ferrari L, Goulart R, Martins MA, Martinez-Navio JM, Fuchs SP, ... ... Burton DR, et al. Potent Plasmablast-Derived Antibodies Elicited by the NIH Dengue Vaccine. Journal of Virology. PMID 28878078 DOI: 10.1128/Jvi.00867-17  1
2017 Julg B, Tartaglia LJ, Keele BF, Wagh K, Pegu A, Sok D, Abbink P, Schmidt SD, Wang K, Chen X, Gordon Joyce M, Georgiev IS, Choe M, Kwong PD, Doria-Rose NA, ... ... Burton DR, et al. Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge. Science Translational Medicine. 9. PMID 28878010 DOI: 10.1126/Scitranslmed.Aal1321  1
2017 Nandin IS, Fong C, Deantonio C, Torreno-Pina JA, Pecetta S, Maldonado P, Gasparrini F, Ordovas-Montanes J, Kazer SW, Kjaer S, Borley DW, Nair U, Coleman JA, Lingwood D, Shalek AK, ... ... Burton DR, et al. Correction: Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies. The Journal of Experimental Medicine. PMID 28827449 DOI: 10.1084/Jem.2017063307262017C  1
2017 Rogers TF, Goodwin EC, Briney B, Sok D, Beutler N, Strubel A, Nedellec R, Le K, Brown ME, Burton DR, Walker LM. Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors. Science Immunology. 2. PMID 28821561 DOI: 10.1126/Sciimmunol.Aan6809  1
2017 Julg B, Sok D, Schmidt SD, Abbink P, Newman RM, Broge T, Linde C, Nkolola J, Le K, Su D, Torabi J, Pack M, Pegu A, Allen TM, Mascola JR, ... Burton DR, et al. Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity Against SHIV in Rhesus Monkeys. Journal of Virology. PMID 28768869 DOI: 10.1128/Jvi.01187-17  1
2017 Magnani DM, Ricciardi MJ, Bailey VK, Gutman MJ, Pedreño-Lopez N, Silveira CGT, Maxwell HS, Domingues A, Gonzalez-Nieto L, Su Q, Newman RM, Pack M, Martins MA, Martinez-Navio JM, Fuchs SP, ... ... Burton DR, et al. Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28750738 DOI: 10.1016/J.Ymthe.2017.06.020  1
2017 Sanjuan Nandin I, Fong C, Deantonio C, Torreno-Pina JA, Pecetta S, Maldonado P, Gasparrini F, Ordovas-Montanes J, Kazer SW, Kjaer S, Borley DW, Nair U, Coleman JA, Lingwood D, Shalek AK, ... ... Burton DR, et al. Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies. The Journal of Experimental Medicine. PMID 28739603 DOI: 10.1084/jem.20170633  1
2017 Martins MA, Shin YC, Gonzalez-Nieto L, Domingues A, Gutman MJ, Maxwell HS, Castro I, Magnani DM, Ricciardi M, Pedreño-Lopez N, Bailey V, Betancourt D, Altman JD, Pauthner M, Burton DR, et al. Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques. Plos Pathogens. 13: e1006529. PMID 28732035 DOI: 10.1371/Journal.Ppat.1006529  1
2017 Sok D, Le KM, Vadnais M, Saye-Francisco K, Jardine JG, Torres J, Berndsen ZT, Kong L, Stanfield R, Ruiz J, Ramos A, Liang CH, Chen PL, Criscitiello MF, Mwangi W, ... ... Burton DR, et al. Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows. Nature. PMID 28726771 DOI: 10.1038/Nature23301  1
2017 Pauthner M, Havenar-Daughton C, Sok D, Nkolola JP, Bastidas R, Boopathy AV, Carnathan DG, Chandrashekar A, Cirelli KM, Cottrell CA, Eroshkin AM, Guenaga J, Kaushik K, Kulp DW, Liu J, ... ... Burton DR, et al. Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches. Immunity. 46: 1073-1088.e6. PMID 28636956 DOI: 10.1016/J.Immuni.2017.05.007  1
2017 Magnani DM, Silveira CGT, Rosen BC, Ricciardi MJ, Pedreño-Lopez N, Gutman MJ, Bailey VK, Maxwell HS, Domingues A, Gonzalez-Nieto L, Avelino-Silva VI, Trindade M, Nogueira J, Oliveira CS, Maestri A, ... ... Burton DR, et al. A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus. Plos Neglected Tropical Diseases. 11: e0005655. PMID 28604797 DOI: 10.1371/Journal.Pntd.0005655  1
2017 Quick J, Grubaugh ND, Pullan ST, Claro IM, Smith AD, Gangavarapu K, Oliveira G, Robles-Sikisaka R, Rogers TF, Beutler NA, Burton DR, Lewis-Ximenez LL, de Jesus JG, Giovanetti M, Hill SC, et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nature Protocols. 12: 1261-1276. PMID 28538739 DOI: 10.1038/Nprot.2017.066  0.01
2017 Lee JH, Andrabi R, Su CY, Yasmeen A, Julien JP, Kong L, Wu NC, McBride R, Sok D, Pauthner M, Cottrell CA, Nieusma T, Blattner C, Paulson JC, Klasse PJ, ... ... Burton DR, et al. A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure. Immunity. 46: 690-702. PMID 28423342 DOI: 10.1016/J.Immuni.2017.03.017  1
2017 Xie J, Sok D, Wu NC, Zheng T, Zhang W, Burton DR, Lerner RA. Immunochemical engineering of cell surfaces to generate virus resistance. Proceedings of the National Academy of Sciences of the United States of America. PMID 28396429 DOI: 10.1073/Pnas.1702764114  1
2017 Cao L, Diedrich JK, Kulp DW, Pauthner M, He L, Park SR, Sok D, Su CY, Delahunty CM, Menis S, Andrabi R, Guenaga J, Georgeson E, Kubitz M, Adachi Y, ... Burton DR, et al. Global site-specific N-glycosylation analysis of HIV envelope glycoprotein. Nature Communications. 8: 14954. PMID 28348411 DOI: 10.1038/Ncomms14954  1
2017 Haynes BF, Burton DR. Developing an HIV vaccine. Science (New York, N.Y.). 355: 1129-1130. PMID 28302812 DOI: 10.1126/science.aan0662  1
2017 Morris CD, Azadnia P, de Val N, Vora N, Honda A, Giang E, Saye-Francisco K, Cheng Y, Lin X, Mann CJ, Tang J, Sok D, Burton DR, Law M, Ward AB, et al. Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers. Mbio. 8. PMID 28246356 DOI: 10.1128/mBio.00036-17  1
2017 Irimia A, Serra AM, Sarkar A, Jacak R, Kalyuzhniy O, Sok D, Saye-Francisco KL, Schiffner T, Tingle R, Kubitz M, Adachi Y, Stanfield RL, Deller MC, Burton DR, Schief WR, et al. Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design. Plos Pathogens. 13: e1006212. PMID 28225819 DOI: 10.1371/Journal.Ppat.1006212  1
2017 Burton DR. What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise. Cold Spring Harbor Perspectives in Biology. PMID 28159875 DOI: 10.1101/cshperspect.a030262  0.01
2017 McCoy LE, Burton DR. Identification and specificity of broadly neutralizing antibodies against HIV. Immunological Reviews. 275: 11-20. PMID 28133814 DOI: 10.1111/imr.12484  1
2017 Freund NT, Wang H, Scharf L, Nogueira L, Horwitz JA, Bar-On Y, Golijanin J, Sievers SA, Sok D, Cai H, Cesar Lorenzi JC, Halper-Stromberg A, Toth I, Piechocka-Trocha A, Gristick HB, ... ... Burton DR, et al. Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller. Science Translational Medicine. 9. PMID 28100831 DOI: 10.1126/Scitranslmed.Aal2144  1
2017 Wibmer CK, Gorman J, Ozorowski G, Bhiman JN, Sheward DJ, Elliott DH, Rouelle J, Smira A, Joyce MG, Ndabambi N, Druz A, Asokan M, Burton DR, Connors M, Abdool Karim SS, et al. Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape. Plos Pathogens. 13: e1006074. PMID 28076415 DOI: 10.1371/Journal.Ppat.1006074  1
2016 Havenar-Daughton C, Carnathan DG, Torrents de la Peña A, Pauthner M, Briney B, Reiss SM, Wood JS, Kaushik K, van Gils MJ, Rosales SL, van der Woude P, Locci M, Le KM, de Taeye SW, Sok D, ... ... Burton DR, et al. Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer. Cell Reports. 17: 2195-2209. PMID 27880897 DOI: 10.1016/J.Celrep.2016.10.085  1
2016 Sok D, Burton DR. HIV Broadly Neutralizing Antibodies: Taking Good Care Of The 98. Immunity. 45: 958-960. PMID 27851923 DOI: 10.1016/j.immuni.2016.10.033  1
2016 van Gils MJ, van den Kerkhof TL, Ozorowski G, Cottrell CA, Sok D, Pauthner M, Pallesen J, de Val N, Yasmeen A, de Taeye SW, Schorcht A, Gumbs S, Johanna I, Saye-Francisco K, Liang CH, ... ... Burton DR, et al. An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability. Nature Microbiology. 2: 16199. PMID 27841852 DOI: 10.1038/Nmicrobiol.2016.199  1
2016 Jardine JG, Sok D, Julien JP, Briney B, Sarkar A, Liang CH, Scherer EM, Henry Dunand CJ, Adachi Y, Diwanji D, Hsueh J, Jones M, Kalyuzhniy O, Kubitz M, Spencer S, ... ... Burton DR, et al. Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design. Plos Pathogens. 12: e1005905. PMID 27627763 DOI: 10.1371/Journal.Ppat.1005905  1
2016 Steichen JM, Kulp DW, Tokatlian T, Escolano A, Dosenovic P, Stanfield RL, McCoy LE, Ozorowski G, Hu X, Kalyuzhniy O, Briney B, Schiffner T, Garces F, Freund NT, Gitlin AD, ... ... Burton DR, et al. HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies. Immunity. PMID 27617678 DOI: 10.1016/J.Immuni.2016.08.016  1
2016 Briney B, Sok D, Jardine JG, Kulp DW, Skog P, Menis S, Jacak R, Kalyuzhniy O, de Val N, Sesterhenn F, Le KM, Ramos A, Jones M, Saye-Francisco KL, Blane TR, ... ... Burton DR, et al. Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies. Cell. 166: 1459-1470.e11. PMID 27610570 DOI: 10.1016/J.Cell.2016.08.005  1
2016 Escolano A, Steichen JM, Dosenovic P, Kulp DW, Golijanin J, Sok D, Freund NT, Gitlin AD, Oliveira T, Araki T, Lowe S, Chen ST, Heinemann J, Yao KH, Georgeson E, ... ... Burton DR, et al. Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice. Cell. 166: 1445-1458.e12. PMID 27610569 DOI: 10.1016/J.Cell.2016.07.030  1
2016 Sok D, Briney B, Jardine JG, Kulp DW, Menis S, Pauthner M, Wood A, Lee EC, Le KM, Jones M, Ramos A, Kalyuzhniy O, Adachi Y, Kubitz M, MacPherson S, ... ... Burton DR, et al. Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice. Science (New York, N.Y.). PMID 27608668 DOI: 10.1126/Science.Aah3945  1
2016 Jardine JG, Sok D, Julien JP, Briney B, Sarkar A, Liang CH, Scherer EA, Henry Dunand CJ, Adachi Y, Diwanji D, Hsueh J, Jones M, Kalyuzhniy O, Kubitz M, Spencer S, ... Burton DR, et al. Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design. Plos Pathogens. 12: e1005815. PMID 27560183 DOI: 10.1371/Journal.Ppat.1005815  1
2016 Larrick JW, Alfenito MR, Scott JK, Parren PW, Burton DR, Bradbury AR, Lemere CA, Messer A, Huston JS, Carter PJ, Veldman T, Chester KA, Schurrman J, Adams GP, Reichert JM. Antibody Engineering & Therapeutics 2016: The Antibody Society's Annual Meeting December 11-15, 2016, San Diego, CA. Mabs. 0. PMID 27557809 DOI: 10.1080/19420862.2016.1227665  1
2016 McCoy LE, van Gils MJ, Ozorowski G, Messmer T, Briney B, Voss JE, Kulp DW, Macauley MS, Sok D, Pauthner M, Menis S, Cottrell CA, Torres JL, Hsueh J, Schief WR, ... Burton DR, et al. Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies. Cell Reports. PMID 27545891 DOI: 10.1016/J.Celrep.2016.07.074  1
2016 Liu J, Ghneim K, Sok D, Bosche WJ, Li Y, Chipriano E, Berkemeier B, Oswald K, Borducchi E, Cabral C, Peter L, Brinkman A, Shetty M, Jimenez J, Mondesir J, ... ... Burton DR, et al. Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus. Science (New York, N.Y.). PMID 27540005 DOI: 10.1126/Science.Aag0491  1
2016 Sok D, Pauthner M, Briney B, Lee JH, Saye-Francisco KL, Hsueh J, Ramos A, Le KM, Jones M, Jardine JG, Bastidas R, Sarkar A, Liang CH, Shivatare SS, Wu CY, ... ... Burton DR, et al. A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans. Immunity. 45: 31-45. PMID 27438765 DOI: 10.1016/J.Immuni.2016.06.026  1
2016 Voss JE, Macauley MS, Rogers KA, Villinger F, Duan L, Shang L, Fink EA, Andrabi R, Colantonio AD, Robinson JE, Johnson RP, Burton DR, Haase AT. Reproducing SIVΔnef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines. Aids (London, England). PMID 27428745 DOI: 10.1097/Qad.0000000000001199  1
2016 van den Kerkhof TL, de Taeye SW, Boeser-Nunnink BD, Burton DR, Kootstra NA, Schuitemaker H, Sanders RW, van Gils MJ. HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds. Retrovirology. 13: 48. PMID 27388013 DOI: 10.1186/s12977-016-0279-4  1
2016 Deruaz M, Moldt B, Le KM, Power KA, Vrbanac VD, Tanno S, Ghebremichael MS, Allen TM, Tager AM, Burton DR, Luster AD. Protection of Humanized Mice From Repeated Intravaginal HIV Challenge by Passive Immunization: A Model for Studying the Efficacy of Neutralizing Antibodies In Vivo. The Journal of Infectious Diseases. PMID 27357340 DOI: 10.1093/Infdis/Jiw203  1
2016 He L, de Val N, Morris CD, Vora N, Thinnes TC, Kong L, Azadnia P, Sok D, Zhou B, Burton DR, Wilson IA, Nemazee D, Ward AB, Zhu J. Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles. Nature Communications. 7: 12041. PMID 27349934 DOI: 10.1038/Ncomms12041  1
2016 Kong L, He L, de Val N, Vora N, Morris CD, Azadnia P, Sok D, Zhou B, Burton DR, Ward AB, Wilson IA, Zhu J. Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability. Nature Communications. 7: 12040. PMID 27349805 DOI: 10.1038/Ncomms12040  1
2016 Moldt B, Le KM, Carnathan DG, Whitney JB, Schultz N, Lewis MG, Borducchi EN, Smith KM, Mackel JJ, Sweat SL, Hodges AP, Godzik A, Parren PW, Silvestri G, Barouch DH, ... Burton DR, et al. Neutralizing antibody affords comparable protection against vaginal and rectal simian/human immunodeficiency virus challenge in macaques. Aids (London, England). 30: 1543-1551. PMID 27243773 DOI: 10.1097/Qad.0000000000001102  1
2016 MacLeod DT, Choi NM, Briney B, Garces F, Ver LS, Landais E, Murrell B, Wrin T, Kilembe W, Liang CH, Ramos A, Bian CB, Wickramasinghe L, Kong L, Eren K, ... ... Burton DR, et al. Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch. Immunity. 44: 1215-1226. PMID 27192579 DOI: 10.1016/J.Immuni.2016.04.016  1
2016 Kong R, Xu K, Zhou T, Acharya P, Lemmin T, Liu K, Ozorowski G, Soto C, Taft JD, Bailer RT, Cale EM, Chen L, Choi CW, Chuang GY, Doria-Rose NA, ... ... Burton DR, et al. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody. Science (New York, N.Y.). 352: 828-33. PMID 27174988 DOI: 10.1126/Science.Aae0474  1
2016 Burton DR, Hangartner L. Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design. Annual Review of Immunology. 34: 635-59. PMID 27168247 DOI: 10.1146/annurev-immunol-041015-055515  1
2016 von Bredow B, Arias JF, Heyer LN, Moldt B, Le K, Robinson JE, Zolla-Pazner S, Burton DR, Evans DT. Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-specific Monoclonal Antibodies. Journal of Virology. PMID 27122574 DOI: 10.1128/Jvi.00347-16  1
2016 Stewart-Jones GB, Soto C, Lemmin T, Chuang GY, Druz A, Kong R, Thomas PV, Wagh K, Zhou T, Behrens AJ, Bylund T, Choi CW, Davison JR, Georgiev IS, Joyce MG, ... ... Burton DR, et al. Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G. Cell. PMID 27114034 DOI: 10.1016/J.Cell.2016.04.010  1
2016 Briney B, Le K, Zhu J, Burton DR. Clonify: unseeded antibody lineage assignment from next-generation sequencing data. Scientific Reports. 6: 23901. PMID 27102563 DOI: 10.1038/Srep23901  1
2016 Wagh K, Bhattacharya T, Williamson C, Robles A, Bayne M, Garrity J, Rist M, Rademeyer C, Yoon H, Lapedes A, Gao H, Greene K, Louder MK, Kong R, Karim SA, ... Burton DR, et al. Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection. Plos Pathogens. 12: e1005520. PMID 27028935 DOI: 10.1371/Journal.Ppat.1005520  1
2016 Jardine JG, Kulp DW, Havenar-Daughton C, Sarkar A, Briney B, Sok D, Sesterhenn F, Ereño-Orbea J, Kalyuzhniy O, Deresa I, Hu X, Spencer S, Jones M, Georgeson E, Adachi Y, ... ... Burton DR, et al. HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. Science (New York, N.Y.). 351: 1458-63. PMID 27013733 DOI: 10.1126/Science.Aad9195  1
2016 Moldt B, Le K, Carnathan DG, Whitney JB, Schultz N, Lewis MG, Borducchi E, Smith K, Mackel JJ, Sweat SL, Hodges AP, Godzik A, Parren PW, Silvestri G, Barouch DH, ... Burton DR, et al. Neutralizing antibody affords comparable protection against vaginal and rectal SHIV challenge in macaques. Aids (London, England). PMID 27003033 DOI: 10.1097/QAD.0000000000001102  1
2016 Shivatare SS, Chang SH, Tsai TI, Tseng SY, Shivatare VS, Lin YS, Cheng YY, Ren CT, Lee CC, Pawar S, Tsai CS, Shih HW, Zeng YF, Liang CH, Kwong PD, ... Burton DR, et al. Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies. Nature Chemistry. 8: 338-46. PMID 27001729 DOI: 10.1038/Nchem.2463  1
2016 Behrens AJ, Vasiljevic S, Pritchard LK, Harvey DJ, Andev RS, Krumm SA, Struwe WB, Cupo A, Kumar A, Zitzmann N, Seabright GE, Kramer HB, Spencer DI, Royle L, Lee JH, ... ... Burton DR, et al. Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein. Cell Reports. PMID 26972002 DOI: 10.1016/J.Celrep.2016.02.058  1
2016 Bornholdt ZA, Turner HL, Murin CD, Li W, Sok D, Souders CA, Piper AE, Goff A, Shamblin JD, Wollen SE, Sprague TR, Fusco ML, Pommert KB, Cavacini LA, Smith HL, ... ... Burton DR, et al. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science (New York, N.Y.). PMID 26912366 DOI: 10.1126/Science.Aad5788  1
2016 Krumm SA, Mohammed H, Le KM, Crispin M, Wrin T, Poignard P, Burton DR, Doores KJ. Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies. Retrovirology. 13: 8. PMID 26837192 DOI: 10.1186/s12977-016-0241-5  1
2016 Stapleton JA, Kim J, Hamilton JP, Wu M, Irber LC, Maddamsetti R, Briney B, Newton L, Burton DR, Brown CT, Chan C, Buell CR, Whitehead TA. Haplotype-Phased Synthetic Long Reads from Short-Read Sequencing. Plos One. 11: e0147229. PMID 26789840 DOI: 10.1371/Journal.Pone.0147229  1
2016 Jones TD, Carter PJ, Plückthun A, Vásquez M, Holgate RG, Hötzel I, Popplewell AG, Parren PW, Enzelberger M, Rademaker HJ, Clark MR, Lowe DC, Dahiyat BI, Smith V, Lambert JM, ... ... Burton DR, et al. The INNs and outs of antibody nonproprietary names. Mabs. 8: 1-9. PMID 26716992 DOI: 10.1080/19420862.2015.1114320  1
2016 Zurnic I, Hütter S, Lehmann U, Stanke N, Reh J, Kern T, Lindel F, Gerresheim G, Hamann M, Müllers E, Lesbats P, Cherepanov P, Serrao E, Engelman A, Lindemann D, ... ... Burton D, et al. Proceedings of the Frontiers of Retrovirology Conference 2016 Retrovirology. 13. DOI: 10.1186/S12977-016-0294-5  0.01
2016 Krumm SA, Mohammed H, Le KM, Crispin M, Wrin T, Poignard P, Burton DR, Doores KJ. Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies Retrovirology. 13. DOI: 10.1186/s12977-016-0241-5  1
2015 Garces F, Lee JH, de Val N, Torrents de la Pena A, Kong L, Puchades C, Hua Y, Stanfield RL, Burton DR, Moore JP, Sanders RW, Ward AB, Wilson IA. Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans. Immunity. 43: 1053-63. PMID 26682982 DOI: 10.1016/J.Immuni.2015.11.007  1
2015 Andrabi R, Voss JE, Liang CH, Briney B, McCoy LE, Wu CY, Wong CH, Poignard P, Burton DR. Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design. Immunity. 43: 959-973. PMID 26588781 DOI: 10.1016/J.Immuni.2015.10.014  1
2015 Parren PW, Burton DR, Bradbury A, Huston JS, Carter PJ, Veldman T, Chester KA, Larrick JW, Alfenito MR, Scott JK, Weiner LM, Adams GP, Reichert JM. Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA. Mabs. 7: 981-8. PMID 26421752 DOI: 10.1080/19420862.2015.1089707  1
2015 Lee JH, Leaman DP, Kim AS, Torrents de la Peña A, Sliepen K, Yasmeen A, Derking R, Ramos A, de Taeye SW, Ozorowski G, Klein F, Burton DR, Nussenzweig MC, Poignard P, Moore JP, et al. Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike. Nature Communications. 6: 8167. PMID 26404402 DOI: 10.1038/Ncomms9167  1
2015 O'Shea D, Law J, Egli A, Douglas D, Lund G, Forester S, Lambert J, Law M, Burton DR, Tyrrell DL, Houghton M, Humar A, Kneteman N. Prevention of HCV infection using a broad cross-neutralizing monoclonal antibody (AR4A) and Epigallocatechin-Gallate. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 26389583 DOI: 10.1002/Lt.24344  1
2015 McCoy LE, Falkowska E, Doores KJ, Le K, Sok D, van Gils MJ, Euler Z, Burger JA, Seaman MS, Sanders RW, Schuitemaker H, Poignard P, Wrin T, Burton DR. Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies. Plos Pathogens. 11: e1005110. PMID 26267277 DOI: 10.1371/journal.ppat.1005110  1
2015 Burton DR, Saphire EO. Swift antibodies to counter emerging viruses. Proceedings of the National Academy of Sciences of the United States of America. 112: 10082-3. PMID 26261336 DOI: 10.1073/Pnas.1513050112  1
2015 Hu JK, Crampton JC, Cupo A, Ketas T, van Gils MJ, Sliepen K, de Taeye SW, Sok D, Ozorowski G, Deresa I, Stanfield R, Ward AB, Burton DR, Klasse PJ, Sanders RW, et al. Murine antibody responses to cleaved soluble HIV-1 envelope trimers are highly restricted in specificity. Journal of Virology. PMID 26246566 DOI: 10.1128/Jvi.01653-15  1
2015 Jardine JG, Ota T, Sok D, Pauthner M, Kulp DW, Kalyuzhniy O, Skog PD, Thinnes TC, Bhullar D, Briney B, Menis S, Jones M, Kubitz M, Spencer S, Adachi Y, ... Burton DR, et al. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. Science (New York, N.Y.). PMID 26089355 DOI: 10.1126/Science.Aac5894  1
2015 Sanders RW, van Gils MJ, Derking R, Sok D, Ketas TJ, Burger JA, Ozorowski G, Cupo A, Simonich C, Goo L, Arendt H, Kim HJ, Lee JH, Pugach P, Williams M, ... ... Burton DR, et al. HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science (New York, N.Y.). 349: aac4223. PMID 26089353 DOI: 10.1126/Science.Aac4223  1
2015 Pritchard LK, Vasiljevic S, Ozorowski G, Seabright GE, Cupo A, Ringe R, Kim HJ, Sanders RW, Doores KJ, Burton DR, Wilson IA, Ward AB, Moore JP, Crispin M. Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers. Cell Reports. 11: 1604-13. PMID 26051934 DOI: 10.1016/J.Celrep.2015.05.017  1
2015 Zhou T, Lynch RM, Chen L, Acharya P, Wu X, Doria-Rose NA, Joyce MG, Lingwood D, Soto C, Bailer RT, Ernandes MJ, Kong R, Longo NS, Louder MK, McKee K, ... ... Burton DR, et al. Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors. Cell. 161: 1280-92. PMID 26004070 DOI: 10.1016/J.Cell.2015.05.007  1
2015 Burton DR, Mascola JR. Antibody responses to envelope glycoproteins in HIV-1 infection. Nature Immunology. 16: 571-6. PMID 25988889 DOI: 10.1038/ni.3158  1
2015 Doores KJ, Kong L, Krumm SA, Le KM, Sok D, Laserson U, Garces F, Poignard P, Wilson IA, Burton DR. Correction for Doores et al., Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope. Journal of Virology. 89: 6525. PMID 25979983 DOI: 10.1128/Jvi.00593-15  1
2015 Barbian HJ, Decker JM, Bibollet-Ruche F, Galimidi RP, West AP, Learn GH, Parrish NF, Iyer SS, Li Y, Pace CS, Song R, Huang Y, Denny TN, Mouquet H, Martin L, ... ... Burton DR, et al. Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas. Mbio. 6. PMID 25900654 DOI: 10.1128/Mbio.00296-15  1
2015 Derking R, Ozorowski G, Sliepen K, Yasmeen A, Cupo A, Torres JL, Julien JP, Lee JH, van Montfort T, de Taeye SW, Connors M, Burton DR, Wilson IA, Klasse PJ, Ward AB, et al. Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer. Plos Pathogens. 11: e1004767. PMID 25807248 DOI: 10.1371/Journal.Ppat.1004767  1
2015 Gardner MR, Kattenhorn LM, Kondur HR, von Schaewen M, Dorfman T, Chiang JJ, Haworth KG, Decker JM, Alpert MD, Bailey CC, Neale ES, Fellinger CH, Joshi VR, Fuchs SP, Martinez-Navio JM, ... ... Burton DR, et al. AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges. Nature. 519: 87-91. PMID 25707797 DOI: 10.1038/Nature14264  1
2015 Wang S, Mata-Fink J, Kriegsman B, Hanson M, Irvine DJ, Eisen HN, Burton DR, Wittrup KD, Kardar M, Chakraborty AK. Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies. Cell. 160: 785-97. PMID 25662010 DOI: 10.1016/J.Cell.2015.01.027  1
2015 Pugach P, Ozorowski G, Cupo A, Ringe R, Yasmeen A, de Val N, Derking R, Kim HJ, Korzun J, Golabek M, de Los Reyes K, Ketas TJ, Julien JP, Burton DR, Wilson IA, et al. A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene. Journal of Virology. 89: 3380-95. PMID 25589637 DOI: 10.1128/Jvi.03473-14  1
2015 Asmal M, Luedemann C, Lavine CL, Mach LV, Balachandran H, Brinkley C, Denny TN, Lewis MG, Anderson H, Pal R, Sok D, Le K, Pauthner M, Hahn BH, Shaw GM, ... ... Burton DR, et al. Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes. Virology. 475: 37-45. PMID 25462344 DOI: 10.1016/J.Virol.2014.10.032  1
2015 Doores KJ, Kong L, Krumm SA, Le KM, Sok D, Laserson U, Garces F, Poignard P, Wilson IA, Burton DR. Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope. Journal of Virology. 89: 1105-18. PMID 25378488 DOI: 10.1128/Jvi.02905-14  1
2015 Schuster JE, Cox RG, Hastings AK, Boyd KL, Wadia J, Chen Z, Burton DR, Williamson RA, Williams JV. A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus. The Journal of Infectious Diseases. 211: 216-25. PMID 24864121 DOI: 10.1093/Infdis/Jiu307  1
2015 Asmal M, Luedemann C, Lavine CL, Mach LV, Balachandran H, Brinkley C, Denny TN, Lewis MG, Anderson H, Pal R, Sok D, Le K, Pauthner M, Hahn BH, Shaw GM, ... ... Burton DR, et al. Corrigendum to: Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes [Virology 475 (2015) 37-45] Virology. 478: 155-158. DOI: 10.1016/J.Virol.2015.01.023  1
2015 Munro JB, Gorman J, Ma X, Zhou Z, Arthos J, Burton D, Koff W, Courter J, Smith A, Kwong P, Blanchard S, Mothes W. Conformational Dynamics of Single HIV-1 Envelope Proteins on the Surface of Native Virions Biophysical Journal. 108: 362a-363a. DOI: 10.1016/j.bpj.2014.11.1988  0.01
2014 Larrick JW, Parren P, Huston JS, Plückthun A, Bradbury A, Tomlinson IM, Chester KA, Burton DR, Adams GP, Weiner LM, Scott JK, Alfenito MR, Veldman T, Reichert JM. Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014. Mabs. 6: 1115-23. PMID 25517297 DOI: 10.4161/19420862.2014.971627  1
2014 Sok D, van Gils MJ, Pauthner M, Julien JP, Saye-Francisco KL, Hsueh J, Briney B, Lee JH, Le KM, Lee PS, Hua Y, Seaman MS, Moore JP, Ward AB, Wilson IA, ... ... Burton DR, et al. Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex. Proceedings of the National Academy of Sciences of the United States of America. 111: 17624-9. PMID 25422458 DOI: 10.1073/Pnas.1415789111  1
2014 He L, Sok D, Azadnia P, Hsueh J, Landais E, Simek M, Koff WC, Poignard P, Burton DR, Zhu J. Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding. Scientific Reports. 4: 6778. PMID 25345460 DOI: 10.1038/srep06778  1
2014 Munro JB, Gorman J, Ma X, Zhou Z, Arthos J, Burton DR, Koff WC, Courter JR, Smith AB, Kwong PD, Blanchard SC, Mothes W. Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions. Science (New York, N.Y.). 346: 759-63. PMID 25298114 DOI: 10.1126/Science.1254426  1
2014 Burton DR. Is IgM-like dislocation a common feature of antibody function? Immunology Today. 7: 165-7. PMID 25290200 DOI: 10.1016/0167-5699(86)90166-0  0.01
2014 Garces F, Sok D, Kong L, McBride R, Kim HJ, Saye-Francisco KF, Julien JP, Hua Y, Cupo A, Moore JP, Paulson JC, Ward AB, Burton DR, Wilson IA. Structural evolution of glycan recognition by a family of potent HIV antibodies. Cell. 159: 69-79. PMID 25259921 DOI: 10.1016/J.Cell.2014.09.009  1
2014 Hepler NL, Scheffler K, Weaver S, Murrell B, Richman DD, Burton DR, Poignard P, Smith DM, Kosakovsky Pond SL. IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platform. Plos Computational Biology. 10: e1003842. PMID 25254639 DOI: 10.1371/Journal.Pcbi.1003842  1
2014 de Jong YP, Dorner M, Mommersteeg MC, Xiao JW, Balazs AB, Robbins JB, Winer BY, Gerges S, Vega K, Labitt RN, Donovan BM, Giang E, Krishnan A, Chiriboga L, Charlton MR, ... Burton DR, et al. Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Science Translational Medicine. 6: 254ra129. PMID 25232181 DOI: 10.1126/Scitranslmed.3009512  1
2014 Del Prete GQ, Ailers B, Moldt B, Keele BF, Estes JD, Rodriguez A, Sampias M, Oswald K, Fast R, Trubey CM, Chertova E, Smedley J, LaBranche CC, Montefiori DC, Burton DR, et al. Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins. Cell Host & Microbe. 16: 412-8. PMID 25211081 DOI: 10.1016/J.Chom.2014.08.003  1
2014 Shingai M, Donau OK, Plishka RJ, Buckler-White A, Mascola JR, Nabel GJ, Nason MC, Montefiori D, Moldt B, Poignard P, Diskin R, Bjorkman PJ, Eckhaus MA, Klein F, Mouquet H, ... ... Burton DR, et al. Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques. The Journal of Experimental Medicine. 211: 2061-74. PMID 25155019 DOI: 10.1084/Jem.20132494  1
2014 Li Q, Zeng M, Duan L, Voss JE, Smith AJ, Pambuccian S, Shang L, Wietgrefe S, Southern PJ, Reilly CS, Skinner PJ, Zupancic ML, Carlis JV, Piatak M, Waterman D, ... ... Burton DR, et al. Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry. Journal of Immunology (Baltimore, Md. : 1950). 193: 3113-25. PMID 25135832 DOI: 10.4049/Jimmunol.1400820  1
2014 Zhou T, Zhu J, Yang Y, Gorman J, Ofek G, Srivatsan S, Druz A, Lees CR, Lu G, Soto C, Stuckey J, Burton DR, Koff WC, Connors M, Kwong PD, et al. Transplanting supersites of HIV-1 vulnerability. Plos One. 9: e99881. PMID 24992528 DOI: 10.1371/Journal.Pone.0099881  1
2014 Murin CD, Julien JP, Sok D, Stanfield RL, Khayat R, Cupo A, Moore JP, Burton DR, Wilson IA, Ward AB. Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopy. Journal of Virology. 88: 10177-88. PMID 24965454 DOI: 10.1128/Jvi.01229-14  1
2014 Yasmeen A, Ringe R, Derking R, Cupo A, Julien JP, Burton DR, Ward AB, Wilson IA, Sanders RW, Moore JP, Klasse PJ. Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits. Retrovirology. 11: 41. PMID 24884783 DOI: 10.1186/1742-4690-11-41  1
2014 Sok D, Doores KJ, Briney B, Le KM, Saye-Francisco KL, Ramos A, Kulp DW, Julien JP, Menis S, Wickramasinghe L, Seaman MS, Schief WR, Wilson IA, Poignard P, Burton DR. Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV. Science Translational Medicine. 6: 236ra63. PMID 24828077 DOI: 10.1126/Scitranslmed.3008104  1
2014 Blattner C, Lee JH, Sliepen K, Derking R, Falkowska E, de la Peña AT, Cupo A, Julien JP, van Gils M, Lee PS, Peng W, Paulson JC, Poignard P, Burton DR, Moore JP, et al. Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers. Immunity. 40: 669-80. PMID 24768348 DOI: 10.1016/J.Immuni.2014.04.008  1
2014 Falkowska E, Le KM, Ramos A, Doores KJ, Lee JH, Blattner C, Ramirez A, Derking R, van Gils MJ, Liang CH, Mcbride R, von Bredow B, Shivatare SS, Wu CY, Chan-Hui PY, ... ... Burton DR, et al. Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers. Immunity. 40: 657-68. PMID 24768347 DOI: 10.1016/J.Immuni.2014.04.009  1
2014 Arias JF, Heyer LN, von Bredow B, Weisgrau KL, Moldt B, Burton DR, Rakasz EG, Evans DT. Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 111: 6425-30. PMID 24733916 DOI: 10.1073/pnas.1321507111  1
2014 Diebolder CA, Beurskens FJ, de Jong RN, Koning RI, Strumane K, Lindorfer MA, Voorhorst M, Ugurlar D, Rosati S, Heck AJ, van de Winkel JG, Wilson IA, Koster AJ, Taylor RP, Saphire EO, ... Burton DR, et al. Complement is activated by IgG hexamers assembled at the cell surface. Science (New York, N.Y.). 343: 1260-3. PMID 24626930 DOI: 10.1126/Science.1248943  1
2014 Fisher D, Yonkos L, Ziegler G, Friedel E, Burton D. Acute and chronic toxicity of selected disinfection byproducts to Daphnia magna, Cyprinodon variegatus, and Isochrysis galbana. Water Research. 55: 233-44. PMID 24607524 DOI: 10.1016/J.Watres.2014.01.056  1
2014 Asano S, Gavrilyuk J, Burton DR, Barbas CF. Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc. Acs Medicinal Chemistry Letters. 5: 133-137. PMID 24563723 DOI: 10.1021/Ml400370W  1
2014 Trist HM, Tan PS, Wines BD, Ramsland PA, Orlowski E, Stubbs J, Gardiner EE, Pietersz GA, Kent SJ, Stratov I, Burton DR, Hogarth PM. Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses. Journal of Immunology (Baltimore, Md. : 1950). 192: 792-803. PMID 24342805 DOI: 10.4049/Jimmunol.1301554  0.01
2014 Ruwona TB, Mcbride R, Chappel R, Head SR, Ordoukhanian P, Burton DR, Law M. Optimization of peptide arrays for studying antibodies to hepatitis C virus continuous epitopes. Journal of Immunological Methods. 402: 35-42. PMID 24269751 DOI: 10.1016/j.jim.2013.11.005  1
2014 Eroshkin AM, LeBlanc A, Weekes D, Post K, Li Z, Rajput A, Butera ST, Burton DR, Godzik A. bNAber: database of broadly neutralizing HIV antibodies. Nucleic Acids Research. 42: D1133-9. PMID 24214957 DOI: 10.1093/Nar/Gkt1083  1
2014 Moldt B, Saye-Francisco K, Schultz N, Burton DR, Hessell AJ. Simplifying the synthesis of SIgA: combination of dIgA and rhSC using affinity chromatography. Methods (San Diego, Calif.). 65: 127-32. PMID 23811333 DOI: 10.1016/j.ymeth.2013.06.022  1
2013 Ferguson AL, Falkowska E, Walker LM, Seaman MS, Burton DR, Chakraborty AK. Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data. Plos One. 8: e80562. PMID 24312481 DOI: 10.1371/Journal.Pone.0080562  1
2013 McMichael A, Picker LJ, Moore JP, Burton DR. Another HIV vaccine failure: where to next? Nature Medicine. 19: 1576-7. PMID 24309655 DOI: 10.1038/nm.3413  1
2013 Kong L, Giang E, Nieusma T, Kadam RU, Cogburn KE, Hua Y, Dai X, Stanfield RL, Burton DR, Ward AB, Wilson IA, Law M. Hepatitis C virus E2 envelope glycoprotein core structure. Science (New York, N.Y.). 342: 1090-4. PMID 24288331 DOI: 10.1126/Science.1243876  1
2013 Gupta S, Gach JS, Becerra JC, Phan TB, Pudney J, Moldoveanu Z, Joseph SB, Landucci G, Supnet MJ, Ping LH, Corti D, Moldt B, Hel Z, Lanzavecchia A, Ruprecht RM, ... Burton DR, et al. The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells. Plos Pathogens. 9: e1003776. PMID 24278022 DOI: 10.1371/Journal.Ppat.1003776  1
2013 Sok D, Laserson U, Laserson J, Liu Y, Vigneault F, Julien JP, Briney B, Ramos A, Saye KF, Le K, Mahan A, Wang S, Kardar M, Yaari G, Walker LM, ... ... Burton DR, et al. The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies. Plos Pathogens. 9: e1003754. PMID 24278016 DOI: 10.1371/Journal.Ppat.1003754  1
2013 Sok D, Moldt B, Burton DR. SnapShot: broadly neutralizing antibodies. Cell. 155: 728-728.e1. PMID 24243025 DOI: 10.1016/j.cell.2013.10.009  1
2013 Lyumkis D, Julien JP, de Val N, Cupo A, Potter CS, Klasse PJ, Burton DR, Sanders RW, Moore JP, Carragher B, Wilson IA, Ward AB. Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science (New York, N.Y.). 342: 1484-90. PMID 24179160 DOI: 10.1126/Science.1245627  1
2013 Julien JP, Cupo A, Sok D, Stanfield RL, Lyumkis D, Deller MC, Klasse PJ, Burton DR, Sanders RW, Moore JP, Ward AB, Wilson IA. Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science (New York, N.Y.). 342: 1477-83. PMID 24179159 DOI: 10.1126/Science.1245625  1
2013 Barouch DH, Whitney JB, Moldt B, Klein F, Oliveira TY, Liu J, Stephenson KE, Chang HW, Shekhar K, Gupta S, Nkolola JP, Seaman MS, Smith KM, Borducchi EN, Cabral C, ... ... Burton DR, et al. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature. 503: 224-8. PMID 24172905 DOI: 10.1038/Nature12744  1
2013 Doyle-Cooper C, Hudson KE, Cooper AB, Ota T, Skog P, Dawson PE, Zwick MB, Schief WR, Burton DR, Nemazee D. Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10. Journal of Immunology (Baltimore, Md. : 1950). 191: 3186-91. PMID 23940276 DOI: 10.4049/Jimmunol.1301285  1
2013 Ota T, Doyle-Cooper C, Cooper AB, Doores KJ, Aoki-Ota M, Le K, Schief WR, Wyatt RT, Burton DR, Nemazee D. B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidates. Journal of Immunology (Baltimore, Md. : 1950). 191: 3179-85. PMID 23940273 DOI: 10.4049/Jimmunol.1301283  1
2013 Zhou T, Zhu J, Wu X, Moquin S, Zhang B, Acharya P, Georgiev IS, Altae-Tran HR, Chuang GY, Joyce MG, Do Kwon Y, Longo NS, Louder MK, Luongo T, McKee K, ... ... Burton DR, et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. Immunity. 39: 245-58. PMID 23911655 DOI: 10.1016/J.Immuni.2013.04.012  1
2013 Jaworski JP, Kobie J, Brower Z, Malherbe DC, Landucci G, Sutton WF, Guo B, Reed JS, Leon EJ, Engelmann F, Zheng B, Legasse A, Park B, Dickerson M, Lewis AD, ... ... Burton DR, et al. Neutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaques. Journal of Virology. 87: 10447-59. PMID 23885083 DOI: 10.1128/Jvi.00049-13  1
2013 Amin MN, McLellan JS, Huang W, Orwenyo J, Burton DR, Koff WC, Kwong PD, Wang LX. Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies. Nature Chemical Biology. 9: 521-6. PMID 23831758 DOI: 10.1038/Nchembio.1288  1
2013 Ahmed R, Burton DR. Viral vaccines: past successes and future challenges. Current Opinion in Virology. 3: 307-8. PMID 23809262 DOI: 10.1016/J.Coviro.2013.06.007  1
2013 Sato S, Inokuma T, Otsubo N, Burton DR, Barbas CF. Chemically Programmed Antibodies AS HIV-1 Attachment Inhibitors. Acs Medicinal Chemistry Letters. 4: 460-465. PMID 23750312 DOI: 10.1021/Ml400097Z  1
2013 Koff WC, Burton DR, Johnson PR, Walker BD, King CR, Nabel GJ, Ahmed R, Bhan MK, Plotkin SA. Accelerating next-generation vaccine development for global disease prevention. Science (New York, N.Y.). 340: 1232910. PMID 23723240 DOI: 10.1126/Science.1232910  1
2013 Pancera M, Shahzad-Ul-Hussan S, Doria-Rose NA, McLellan JS, Bailer RT, Dai K, Loesgen S, Louder MK, Staupe RP, Yang Y, Zhang B, Parks R, Eudailey J, Lloyd KE, Blinn J, ... ... Burton DR, et al. Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16. Nature Structural & Molecular Biology. 20: 804-13. PMID 23708607 DOI: 10.1038/Nsmb.2600  1
2013 Kong L, Lee JH, Doores KJ, Murin CD, Julien JP, McBride R, Liu Y, Marozsan A, Cupo A, Klasse PJ, Hoffenberg S, Caulfield M, King CR, Hua Y, Le KM, ... ... Burton DR, et al. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nature Structural & Molecular Biology. 20: 796-803. PMID 23708606 DOI: 10.1038/Nsmb.2594  1
2013 Julien JP, Sok D, Khayat R, Lee JH, Doores KJ, Walker LM, Ramos A, Diwanji DC, Pejchal R, Cupo A, Katpally U, Depetris RS, Stanfield RL, McBride R, Marozsan AJ, ... ... Burton DR, et al. Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans. Plos Pathogens. 9: e1003342. PMID 23658524 DOI: 10.1371/Journal.Ppat.1003342  1
2013 Jardine J, Julien JP, Menis S, Ota T, Kalyuzhniy O, McGuire A, Sok D, Huang PS, MacPherson S, Jones M, Nieusma T, Mathison J, Baker D, Ward AB, Burton DR, et al. Rational HIV immunogen design to target specific germline B cell receptors. Science (New York, N.Y.). 340: 711-6. PMID 23539181 DOI: 10.1126/Science.1234150  1
2013 Zhu J, Ofek G, Yang Y, Zhang B, Louder MK, Lu G, McKee K, Pancera M, Skinner J, Zhang Z, Parks R, Eudailey J, Lloyd KE, Blinn J, Alam SM, ... ... Burton DR, et al. Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains. Proceedings of the National Academy of Sciences of the United States of America. 110: 6470-5. PMID 23536288 DOI: 10.1073/Pnas.1219320110  1
2013 Hoffenberg S, Powell R, Carpov A, Wagner D, Wilson A, Kosakovsky Pond S, Lindsay R, Arendt H, Destefano J, Phogat S, Poignard P, Fling SP, Simek M, Labranche C, Montefiori D, ... ... Burton D, et al. Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes. Journal of Virology. 87: 5372-83. PMID 23468492 DOI: 10.1128/Jvi.02827-12  1
2013 Pancera M, Yang Y, Louder MK, Gorman J, Lu G, McLellan JS, Stuckey J, Zhu J, Burton DR, Koff WC, Mascola JR, Kwong PD. N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function. Plos One. 8: e55701. PMID 23431362 DOI: 10.1371/journal.pone.0055701  1
2013 Gavrilyuk J, Ban H, Uehara H, Sirk SJ, Saye-Francisco K, Cuevas A, Zablowsky E, Oza A, Seaman MS, Burton DR, Barbas CF. Antibody conjugation approach enhances breadth and potency of neutralization of anti-HIV-1 antibodies and CD4-IgG. Journal of Virology. 87: 4985-93. PMID 23427154 DOI: 10.1128/Jvi.03146-12  1
2013 Hoot S, McGuire AT, Cohen KW, Strong RK, Hangartner L, Klein F, Diskin R, Scheid JF, Sather DN, Burton DR, Stamatatos L. Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs. Plos Pathogens. 9: e1003106. PMID 23300456 DOI: 10.1371/Journal.Ppat.1003106  1
2013 Doores KJ, Huber M, Le KM, Wang SK, Doyle-Cooper C, Cooper A, Pantophlet R, Wong CH, Nemazee D, Burton DR. 2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies. Journal of Virology. 87: 2234-41. PMID 23221565 DOI: 10.1128/Jvi.02820-12  1
2013 Benhnia MR, Maybeno M, Blum D, Aguilar-Sino R, Matho M, Meng X, Head S, Felgner PL, Zajonc DM, Koriazova L, Kato S, Burton DR, Xiang Y, Crowe JE, Peters B, et al. Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine. Journal of Virology. 87: 1569-85. PMID 23152530 DOI: 10.1128/Jvi.02152-12  1
2013 Sok D, Laserson U, Laserson J, Liu Y, Vigneault F, Julien J, Briney B, Ramos A, Saye KF, Le K, Mahan A, Wang S, Kardar M, Yaari G, Walker LM, ... ... Burton DR, et al. Correction: The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies Plos Pathogens. 9. DOI: 10.1371/annotation/f1f8c791-61e9-45c6-a455-92c6dadf9f06  0.01
2013 Hoot S, McGuire AT, Cohen KW, Strong RK, Hangartner L, Klein F, Diskin R, Scheid JF, Sather DN, Burton DR, Stamatatos L. Correction: Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs Plos Pathogens. 9. DOI: 10.1371/Annotation/Ed7C0148-97Eb-4416-824D-6E6D1Aaeceef  0.01
2013 Gupta S, Gach JS, Becerra JC, Phan TB, Pudney J, Moldoveanu Z, Joseph SB, Landucci G, Supnet MJ, Ping L, Corti D, Moldt B, Hel Z, Lanzavecchia A, Ruprecht RM, ... Burton DR, et al. Correction: The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells Plos Pathogens. 9. DOI: 10.1371/annotation/31430955-703b-484a-96eb-e180f917d683  0.01
2013 Beurskens FJ, de Jong RN, Verploegen S, Voorhorst M, Strumane K, Lindorfer MA, Taylor RP, Saphire EO, Burton D, Schuurman J, Parren PW. Enhanced IgG Hexamerization Mediates Efficient C1q Docking and Complement-Dependent Cytotoxicity; Preclinical Proof Of Concept On Primary CLL and Burkitt Lymphoma Blood. 122: 375-375. DOI: 10.1182/Blood.V122.21.375.375  0.01
2013 de Jong Y, Dorner M, Balazs A, Robbins J, Labitt R, Donovan B, Krishnan A, Charlton M, Chiriboga L, Burton D, Rice C, Baltimore D, Law M, Ploss A. 1146 THE EFFECTS OF BROADLY NEUTRALIZING ANTIBODIES IN EXPERIMENTAL HCV INFECTION Journal of Hepatology. 58: S466-S467. DOI: 10.1016/S0168-8278(13)61147-2  0.01
2013 Beurskens F, de Jong R, Voorhorst M, Strumane K, Lindorfer M, Taylor R, Ollmann-Saphire E, Burton D, Schuurman J, Parren P. IgG hexamerization mediates efficient C1q docking and complement-dependent cytotoxicity (CDC) Molecular Immunology. 56: 240-241. DOI: 10.1016/J.Molimm.2013.05.012  0.01
2012 Moldt B, Rakasz EG, Schultz N, Chan-Hui PY, Swiderek K, Weisgrau KL, Piaskowski SM, Bergman Z, Watkins DI, Poignard P, Burton DR. Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo. Proceedings of the National Academy of Sciences of the United States of America. 109: 18921-5. PMID 23100539 DOI: 10.1073/Pnas.1214785109  1
2012 Burton DR, Ahmed R, Barouch DH, Butera ST, Crotty S, Godzik A, Kaufmann DE, McElrath MJ, Nussenzweig MC, Pulendran B, Scanlan CN, Schief WR, Silvestri G, Streeck H, Walker BD, et al. A Blueprint for HIV Vaccine Discovery. Cell Host & Microbe. 12: 396-407. PMID 23084910 DOI: 10.1016/J.Chom.2012.09.008  1
2012 Ota T, Doyle-Cooper C, Cooper AB, Huber M, Falkowska E, Doores KJ, Hangartner L, Le K, Sok D, Jardine J, Lifson J, Wu X, Mascola JR, Poignard P, Binley JM, ... ... Burton DR, et al. Anti-HIV B Cell lines as candidate vaccine biosensors. Journal of Immunology (Baltimore, Md. : 1950). 189: 4816-24. PMID 23066156 DOI: 10.4049/Jimmunol.1202165  1
2012 Zhu J, O'Dell S, Ofek G, Pancera M, Wu X, Zhang B, Zhang Z, Mullikin JC, Simek M, Burton DR, Koff WC, Shapiro L, Mascola JR, Kwong PD. Somatic Populations of PGT135-137 HIV-1-Neutralizing Antibodies Identified by 454 Pyrosequencing and Bioinformatics. Frontiers in Microbiology. 3: 315. PMID 23024643 DOI: 10.3389/Fmicb.2012.00315  1
2012 Poignard P, Moldt B, Maloveste K, Campos N, Olson WC, Rakasz E, Watkins DI, Burton DR. Protection against high-dose highly pathogenic mucosal SIV challenge at very low serum neutralizing titers of the antibody-like molecule CD4-igG2 Plos One. 7. PMID 22848744 DOI: 10.1371/Journal.Pone.0042209  1
2012 Burton DR, Poignard P, Stanfield RL, Wilson IA. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science (New York, N.Y.). 337: 183-6. PMID 22798606 DOI: 10.1126/Science.1225416  1
2012 Doria-Rose NA, Georgiev I, O'Dell S, Chuang GY, Staupe RP, McLellan JS, Gorman J, Pancera M, Bonsignori M, Haynes BF, Burton DR, Koff WC, Kwong PD, Mascola JR. A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodies. Journal of Virology. 86: 8319-23. PMID 22623764 DOI: 10.1128/Jvi.00696-12  1
2012 Kong L, Giang E, Robbins JB, Stanfield RL, Burton DR, Wilson IA, Law M. Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1. Proceedings of the National Academy of Sciences of the United States of America. 109: 9499-504. PMID 22623528 DOI: 10.1073/Pnas.1202924109  1
2012 Giang E, Dorner M, Prentoe JC, Dreux M, Evans MJ, Bukh J, Rice CM, Ploss A, Burton DR, Law M. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America. 109: 6205-10. PMID 22492964 DOI: 10.1073/Pnas.1114927109  1
2012 Falkowska E, Ramos A, Feng Y, Zhou T, Moquin S, Walker LM, Wu X, Seaman MS, Wrin T, Kwong PD, Wyatt RT, Mascola JR, Poignard P, Burton DR. PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4. Journal of Virology. 86: 4394-403. PMID 22345481 DOI: 10.1128/JVI.06973-11  1
2012 Ahmed FK, Clark BE, Burton DR, Pantophlet R. An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site. Vaccine. 30: 922-30. PMID 22142583 DOI: 10.1016/j.vaccine.2011.11.089  1
2012 Hoffenberg S, Pond SK, Carpov A, Wagner D, Wilson A, Powell R, Lindsay R, Arendt H, DeStefano J, Poignard P, Simek M, Fling S, Phogat S, Labranche C, Montefiori D, ... Burton D, et al. Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses Retrovirology. 9: 1-1. DOI: 10.1186/1742-4690-9-S2-O7  1
2012 Burton DR, Poignard P, Stanfield RL, Wilson IA. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses Science. 337: 183-186. DOI: 10.1126/science.1225416  1
2012 Kong L, Julien JP, Calarese D, Scanlan C, Lee HK, Rudd P, Wong CH, Dwek RA, Burton DR, Wilson IA. Toward a carbohydrate-based HIV-1 vaccine Acs Symposium Series. 1102: 187-215. DOI: 10.1021/bk-2012-1102.ch007  1
2012 Ackerman ME, Moldt B, Wyatt RT, Dugast A, McAndrew E, Tsoukas S, Jost S, Berger CT, Sciaranghella G, Liu Q, Irvine DJ, Burton DR, Alter G. Corrigendum to “A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples” Journal of Immunological Methods. 376: 156. DOI: 10.1016/J.Jim.2011.12.006  0.01
2011 Walker LM, Sok D, Nishimura Y, Donau O, Sadjadpour R, Gautam R, Shingai M, Pejchal R, Ramos A, Simek MD, Geng Y, Wilson IA, Poignard P, Martin MA, Burton DR. Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque. Proceedings of the National Academy of Sciences of the United States of America. 108: 20125-9. PMID 22123961 DOI: 10.1073/Pnas.1117531108  1
2011 McLellan JS, Pancera M, Carrico C, Gorman J, Julien JP, Khayat R, Louder R, Pejchal R, Sastry M, Dai K, O'Dell S, Patel N, Shahzad-ul-Hussan S, Yang Y, Zhang B, ... ... Burton DR, et al. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature. 480: 336-43. PMID 22113616 DOI: 10.1038/Nature10696  1
2011 Wahl-Jensen V, Kurz S, Feldmann F, Buehler LK, Kindrachuk J, DeFilippis V, da Silva Correia J, Früh K, Kuhn JH, Burton DR, Feldmann H. Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression. Plos Neglected Tropical Diseases. 5: e1359. PMID 22028943 DOI: 10.1371/Journal.Pntd.0001359  0.01
2011 Pejchal R, Doores KJ, Walker LM, Khayat R, Huang PS, Wang SK, Stanfield RL, Julien JP, Ramos A, Crispin M, Depetris R, Katpally U, Marozsan A, Cupo A, Maloveste S, ... ... Burton DR, et al. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science (New York, N.Y.). 334: 1097-103. PMID 21998254 DOI: 10.1126/Science.1213256  1
2011 Bonomelli C, Doores KJ, Dunlop DC, Thaney V, Dwek RA, Burton DR, Crispin M, Scanlan CN. The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade. Plos One. 6: e23521. PMID 21858152 DOI: 10.1371/Journal.Pone.0023521  1
2011 Walker LM, Huber M, Doores KJ, Falkowska E, Pejchal R, Julien JP, Wang SK, Ramos A, Chan-Hui PY, Moyle M, Mitcham JL, Hammond PW, Olsen OA, Phung P, Fling S, ... ... Burton DR, et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature. 477: 466-70. PMID 21849977 DOI: 10.1038/Nature10373  1
2011 Moldt B, Schultz N, Dunlop DC, Alpert MD, Harvey JD, Evans DT, Poignard P, Hessell AJ, Burton DR. A panel of IgG1 b12 variants with selectively diminished or enhanced affinity for Fcγ receptors to define the role of effector functions in protection against HIV. Journal of Virology. 85: 10572-81. PMID 21849450 DOI: 10.1128/Jvi.05541-11  1
2011 Nicolaou KC, Ellery SP, Rivas F, Saye K, Rogers E, Workinger TJ, Schallenberger M, Tawatao R, Montero A, Hessell A, Romesberg F, Carson D, Burton D. Synthesis and biological evaluation of 2',4'- and 3',4'-bridged nucleoside analogues. Bioorganic & Medicinal Chemistry. 19: 5648-69. PMID 21840722 DOI: 10.1016/J.Bmc.2011.07.022  1
2011 Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, Wang C, Chen X, Longo NS, Louder M, McKee K, O'Dell S, Perfetto S, Schmidt SD, Shi W, Wu L, ... ... Burton DR, et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science (New York, N.Y.). 333: 1593-602. PMID 21835983 DOI: 10.1126/science.1207532  1
2011 Scheid JF, Mouquet H, Ueberheide B, Diskin R, Klein F, Oliveira TY, Pietzsch J, Fenyo D, Abadir A, Velinzon K, Hurley A, Myung S, Boulad F, Poignard P, Burton DR, et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science (New York, N.Y.). 333: 1633-7. PMID 21764753 DOI: 10.1126/Science.1207227  1
2011 Agrawal N, Leaman DP, Rowcliffe E, Kinkead H, Nohria R, Akagi J, Bauer K, Du SX, Whalen RG, Burton DR, Zwick MB. Functional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1). Plos One. 6: e21339. PMID 21738637 DOI: 10.1371/Journal.Pone.0021339  1
2011 Du SX, Xu L, Zhang W, Tang S, Boenig RI, Chen H, Mariano EB, Zwick MB, Parren PW, Burton DR, Wrin T, Petropoulos CJ, Ballantyne JA, Chambers M, Whalen RG. A directed molecular evolution approach to improved immunogenicity of the HIV-1 envelope glycoprotein. Plos One. 6: e20927. PMID 21738594 DOI: 10.1371/journal.pone.0020927  1
2011 Li Y, O'Dell S, Walker LM, Wu X, Guenaga J, Feng Y, Schmidt SD, McKee K, Louder MK, Ledgerwood JE, Graham BS, Haynes BF, Burton DR, Wyatt RT, Mascola JR. Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01. Journal of Virology. 85: 8954-67. PMID 21715490 DOI: 10.1128/Jvi.00754-11  1
2011 Burton DR, Hessell AJ, Keele BF, Klasse PJ, Ketas TA, Moldt B, Dunlop DC, Poignard P, Doyle LA, Cavacini L, Veazey RS, Moore JP. Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody. Proceedings of the National Academy of Sciences of the United States of America. 108: 11181-6. PMID 21690411 DOI: 10.1073/pnas.1103012108  1
2011 Dorner M, Horwitz JA, Robbins JB, Barry WT, Feng Q, Mu K, Jones CT, Schoggins JW, Catanese MT, Burton DR, Law M, Rice CM, Ploss A. A genetically humanized mouse model for hepatitis C virus infection. Nature. 474: 208-11. PMID 21654804 DOI: 10.1038/Nature10168  1
2011 Chakrabarti BK, Walker LM, Guenaga JF, Ghobbeh A, Poignard P, Burton DR, Wyatt RT. Direct antibody access to the HIV-1 membrane-proximal external region positively correlates with neutralization sensitivity. Journal of Virology. 85: 8217-26. PMID 21653673 DOI: 10.1128/JVI.00756-11  1
2011 Nicolaou KC, Sanchini S, Sarlah D, Lu G, Wu TR, Nomura DK, Cravatt BF, Cubitt B, de la Torre JC, Hessell AJ, Burton DR. Design, synthesis, and biological evaluation of a biyouyanagin compound library. Proceedings of the National Academy of Sciences of the United States of America. 108: 6715-20. PMID 21245351 DOI: 10.1073/Pnas.1015258108  1
2011 Ackerman ME, Moldt B, Wyatt RT, Dugast AS, McAndrew E, Tsoukas S, Jost S, Berger CT, Sciaranghella G, Liu Q, Irvine DJ, Burton DR, Alter G. A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples. Journal of Immunological Methods. 366: 8-19. PMID 21192942 DOI: 10.1016/J.Jim.2010.12.016  1
2011 Weinfurter JT, May GE, Soma T, Hessell AJ, León EJ, Macnair CE, Piaskowski SM, Weisgrau K, Furlott J, Maness NJ, Reed J, Wilson NA, Rakasz EG, Burton DR, Friedrich TC. Macaque long-term nonprogressors resist superinfection with multiple CD8+ T cell escape variants of simian immunodeficiency virus. Journal of Virology. 85: 530-41. PMID 20962091 DOI: 10.1128/JVI.01025-10  1
2010 Burton DR. Scaffolding to build a rational vaccine design strategy. Proceedings of the National Academy of Sciences of the United States of America. 107: 17859-60. PMID 20937874 DOI: 10.1073/pnas.1012923107  0.08
2010 Ng CT, Jaworski JP, Jayaraman P, Sutton WF, Delio P, Kuller L, Anderson D, Landucci G, Richardson BA, Burton DR, Forthal DN, Haigwood NL. Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nature Medicine. 16: 1117-9. PMID 20890292 DOI: 10.1038/Nm.2233  1
2010 Doores KJ, Fulton Z, Hong V, Patel MK, Scanlan CN, Wormald MR, Finn MG, Burton DR, Wilson IA, Davis BG. A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity. Proceedings of the National Academy of Sciences of the United States of America. 107: 17107-12. PMID 20852065 DOI: 10.1073/Pnas.1002717107  1
2010 Gavrilyuk J, Uehara H, Otsubo N, Hessell A, Burton DR, Barbas CF. Potent inhibition of HIV-1 entry with a chemically programmed antibody aided by an efficient organocatalytic synthesis. Chembiochem : a European Journal of Chemical Biology. 11: 2113-8. PMID 20845359 DOI: 10.1002/Cbic.201000432  1
2010 Burton DR, Weiss RA. AIDS/HIV. A boost for HIV vaccine design. Science (New York, N.Y.). 329: 770-3. PMID 20705840 DOI: 10.1126/Science.1194693  0.01
2010 Huber M, Le KM, Doores KJ, Fulton Z, Stanfield RL, Wilson IA, Burton DR. Very few substitutions in a germ line antibody are required to initiate significant domain exchange. Journal of Virology. 84: 10700-7. PMID 20702640 DOI: 10.1128/Jvi.01111-10  1
2010 Doores KJ, Fulton Z, Huber M, Wilson IA, Burton DR. Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged. Journal of Virology. 84: 10690-9. PMID 20702629 DOI: 10.1128/Jvi.01110-10  0.08
2010 Walker LM, Simek MD, Priddy F, Gach JS, Wagner D, Zwick MB, Phogat SK, Poignard P, Burton DR. A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals Plos Pathogens. 6: 11-12. PMID 20700449 DOI: 10.1371/journal.ppat.1001028  1
2010 Doores KJ, Burton DR. Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16. Journal of Virology. 84: 10510-21. PMID 20686044 DOI: 10.1128/JVI.00552-10  0.04
2010 Doores KJ, Bonomelli C, Harvey DJ, Vasiljevic S, Dwek RA, Burton DR, Crispin M, Scanlan CN. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proceedings of the National Academy of Sciences of the United States of America. 107: 13800-5. PMID 20643940 DOI: 10.1073/Pnas.1006498107  1
2010 Reynolds MR, Weiler AM, Piaskowski SM, Kolar HL, Hessell AJ, Weiker M, Weisgrau KL, León EJ, Rogers WE, Makowsky R, McDermott AB, Boyle R, Wilson NA, Allison DB, Burton DR, et al. Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge. Journal of Virology. 84: 9190-9. PMID 20592091 DOI: 10.1128/Jvi.00041-10  1
2010 Pejchal R, Walker LM, Stanfield RL, Phogat SK, Koff WC, Poignard P, Burton DR, Wilson IA. Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1. Proceedings of the National Academy of Sciences of the United States of America. 107: 11483-8. PMID 20534513 DOI: 10.1073/Pnas.1004600107  1
2010 Astronomo RD, Kaltgrad E, Udit AK, Wang SK, Doores KJ, Huang CY, Pantophlet R, Paulson JC, Wong CH, Finn MG, Burton DR. Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds. Chemistry & Biology. 17: 357-70. PMID 20416507 DOI: 10.1016/J.Chembiol.2010.03.012  1
2010 Astronomo RD, Burton DR. Carbohydrate vaccines: developing sweet solutions to sticky situations? Nature Reviews. Drug Discovery. 9: 308-24. PMID 20357803 DOI: 10.1038/Nrd3012  1
2010 Shedlock DJ, Bailey MA, Popernack PM, Cunningham JM, Burton DR, Sullivan NJ. Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms. Virology. 401: 228-35. PMID 20304456 DOI: 10.1016/j.virol.2010.02.029  1
2010 Walker LM, Burton DR. Rational antibody-based HIV-1 vaccine design: current approaches and future directions. Current Opinion in Immunology. 22: 358-66. PMID 20299194 DOI: 10.1016/j.coi.2010.02.012  0.01
2010 Scherer EM, Leaman DP, Zwick MB, McMichael AJ, Burton DR. Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions Proceedings of the National Academy of Sciences of the United States of America. 107: 1529-1534. PMID 20080706 DOI: 10.1073/Pnas.0909680107  1
2010 Hessell AJ, Rakasz EG, Tehrani DM, Huber M, Weisgrau KL, Landucci G, Forthal DN, Koff WC, Poignard P, Watkins DI, Burton DR. Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L. Journal of Virology. 84: 1302-13. PMID 19906907 DOI: 10.1128/Jvi.01272-09  1
2009 Chen L, Kwon YD, Zhou T, Wu X, O'Dell S, Cavacini L, Hessell AJ, Pancera M, Tang M, Xu L, Yang ZY, Zhang MY, Arthos J, Burton DR, Dimitrov DS, et al. Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120. Science (New York, N.Y.). 326: 1123-7. PMID 19965434 DOI: 10.1126/Science.1175868  1
2009 Lee JE, Fusco ML, Abelson DM, Hessell AJ, Burton DR, Saphire EO. Techniques and tactics used in determining the structure of the trimeric ebolavirus glycoprotein. Acta Crystallographica. Section D, Biological Crystallography. 65: 1162-80. PMID 19923712 DOI: 10.1107/S0907444909032314  1
2009 Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, Goss JL, Wrin T, Simek MD, Fling S, Mitcham JL, Lehrman JK, Priddy FH, Olsen OA, Frey SM, Hammond PW, ... ... Burton DR, et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science (New York, N.Y.). 326: 285-9. PMID 19729618 DOI: 10.1126/science.1178746  1
2009 Hessell AJ, Poignard P, Hunter M, Hangartner L, Tehrani DM, Bleeker WK, Parren PWHI, Marx PA, Burton DR. Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques Nature Medicine. 15: 951-954. PMID 19525965 DOI: 10.1038/nm.1974  1
2009 Stamatatos L, Morris L, Burton DR, Mascola JR. Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nature Medicine. 15: 866-70. PMID 19525964 DOI: 10.1038/Nm.1949  1
2009 Pejchal R, Gach JS, Brunel FM, Cardoso RM, Stanfield RL, Dawson PE, Burton DR, Zwick MB, Wilson IA. A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies. Journal of Virology. 83: 8451-62. PMID 19515770 DOI: 10.1128/Jvi.00685-09  1
2009 Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, Lehrman JK, Boaz M, Tarragona-Fiol T, Miiro G, Birungi J, Pozniak A, McPhee DA, Manigart O, Karita E, ... ... Burton DR, et al. Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm. Journal of Virology. 83: 7337-48. PMID 19439467 DOI: 10.1128/JVI.00110-09  0.01
2009 Hessell AJ, Rakasz EG, Poignard P, Hangartner L, Landucci G, Forthal DN, Koff WC, Watkins DI, Burton DR. Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. Plos Pathogens. 5: e1000433. PMID 19436712 DOI: 10.1371/Journal.Ppat.1000433  0.01
2009 Walker LM, Bowley DR, Burton DR. Efficient recovery of high-affinity antibodies from a single-chain Fab yeast display library. Journal of Molecular Biology. 389: 365-75. PMID 19376130 DOI: 10.1016/j.jmb.2009.04.019  0.01
2009 Burton DR, Poignard P. HIV: Immune memory downloaded. Nature. 458: 584-5. PMID 19340071 DOI: 10.1038/458584a  0.01
2009 Parren PW, Burton DR. Immunology. Two-in-one designer antibodies. Science (New York, N.Y.). 323: 1567-8. PMID 19299606 DOI: 10.1126/science.1172253  0.01
2009 Wu L, Zhou T, Yang ZY, Svehla K, O'Dell S, Louder MK, Xu L, Mascola JR, Burton DR, Hoxie JA, Doms RW, Kwong PD, Nabel GJ. Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain. Journal of Virology. 83: 5077-86. PMID 19264769 DOI: 10.1128/Jvi.02600-08  1
2009 Bowley DR, Jones TM, Burton DR, Lerner RA. Libraries against libraries for combinatorial selection of replicating antigen-antibody pairs. Proceedings of the National Academy of Sciences of the United States of America. 106: 1380-5. PMID 19139405 DOI: 10.1073/Pnas.0812291106  1
2009 Duenas-Decamp MJ, Peters PJ, Burton D, Clapham PR. Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopes. Journal of Virology. 83: 2575-2583. PMID 19129457 DOI: 10.1128/Jvi.02133-08  1
2009 Dunlop DC, Mansab F, Doores K, Zitzmann N, Smith D, Burton D, Dwek R, Scanlan C. P05-11. Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope Retrovirology. 6: P87. DOI: 10.1186/1742-4690-6-S3-P87  1
2009 Walker LL, Poignard P, Simek M, Phogat S, Koff W, Burton D. P04-51 LB. The epitopes of two newly identified broad and potent neutralizing antibodies, PG9 and PG16 Retrovirology. 6: 391. DOI: 10.1186/1742-4690-6-S3-P391  1
2009 Phogat S, Walker L, Wagner D, Chan-Hui P, Simek M, Phung P, Wrin T, Mitcham J, Investigator P, Kaminsky S, Zamb T, Moyle M, Koff W, Burton D. S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target Retrovirology. 6: 1-1. DOI: 10.1186/1742-4690-6-S3-O6  1
2008 Pantophlet R, Wang M, Aguilar-Sino RO, Burton DR. The human immunodeficiency virus type 1 envelope spike of primary viruses can suppress antibody access to variable regions. Journal of Virology. 83: 1649-59. PMID 19036813 DOI: 10.1128/JVI.02046-08  0.04
2008 Reynolds MR, Weiler AM, Weisgrau KL, Piaskowski SM, Furlott JR, Weinfurter JT, Kaizu M, Soma T, León EJ, MacNair C, Leaman DP, Zwick MB, Gostick E, Musani SK, Price DA, ... ... Burton DR, et al. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. The Journal of Experimental Medicine. 205: 2537-50. PMID 18838548 DOI: 10.1084/Jem.20081524  1
2008 Pantophlet R, Wrin T, Cavacini LA, Robinson JE, Burton DR. Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity. Virology. 381: 251-60. PMID 18822440 DOI: 10.1016/j.virol.2008.08.032  1
2008 Cohen C, Forzan M, Sproat B, Pantophlet R, McGowan I, Burton D, James W. An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site. Virology. 381: 46-54. PMID 18799178 DOI: 10.1016/J.Virol.2008.08.025  1
2008 Pollock S, Dwek RA, Burton DR, Zitzmann N. N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery. Aids (London, England). 22: 1961-9. PMID 18753929 DOI: 10.1097/Qad.0B013E32830Efd96  1
2008 Zwick MB, Gach JS, Burton DR. A welcome burst of human antibodies Nature Biotechnology. 26: 886-887. PMID 18688242 DOI: 10.1038/nbt0808-886  1
2008 Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, Martin M, Overbaugh J, Watkins DI, Mahmoud A, Greene WC. HIV vaccine research: the way forward. Science (New York, N.Y.). 321: 530-2. PMID 18653883 DOI: 10.1126/Science.1161000  1
2008 Nicolaou KC, Wu TR, Sarlah D, Shaw DM, Rowcliffe E, Burton DR. Total synthesis, revised structure, and biological evaluation of biyouyanagin A and analogues thereof. Journal of the American Chemical Society. 130: 11114-21. PMID 18646750 DOI: 10.1021/Ja802805C  1
2008 Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, Saphire EO. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature. 454: 177-82. PMID 18615077 DOI: 10.1038/Nature07082  1
2008 Watkins DI, Burton DR, Kallas EG, Moore JP, Koff WC. Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans. Nature Medicine. 14: 617-21. PMID 18535579 DOI: 10.1038/Nm.F.1759  0.01
2008 Nelson JD, Kinkead H, Brunel FM, Leaman D, Jensen R, Louis JM, Maruyama T, Bewley CA, Bowdish K, Clore GM, Dawson PE, Frederickson S, Mage RG, Richman DD, Burton DR, et al. Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics. Virology. 377: 170-83. PMID 18499210 DOI: 10.1016/J.Virol.2008.04.005  1
2008 Walker BD, Burton DR. Toward an AIDS vaccine. Science (New York, N.Y.). 320: 760-4. PMID 18467582 DOI: 10.1126/science.1152622  0.01
2008 Astronomo RD, Lee HK, Scanlan CN, Pantophlet R, Huang CY, Wilson IA, Blixt O, Dwek RA, Wong CH, Burton DR. A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120. Journal of Virology. 82: 6359-68. PMID 18434393 DOI: 10.1128/Jvi.00293-08  1
2008 Scanlan CN, Burton DR, Dwek RA. Making autoantibodies safe. Proceedings of the National Academy of Sciences of the United States of America. 105: 4081-2. PMID 18344326 DOI: 10.1073/Pnas.0801192105  1
2008 Wang SK, Liang PH, Astronomo RD, Hsu TL, Hsieh SL, Burton DR, Wong CH. Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN. Proceedings of the National Academy of Sciences of the United States of America. 105: 3690-5. PMID 18310320 DOI: 10.1073/Pnas.0712326105  1
2008 Selvarajah S, Puffer BA, Lee FH, Zhu P, Li Y, Wyatt R, Roux KH, Doms RW, Burton DR. Focused dampening of antibody response to the immunodominant variable loops by engineered soluble gp140. Aids Research and Human Retroviruses. 24: 301-14. PMID 18284327 DOI: 10.1089/Aid.2007.0158  1
2008 Peters PJ, Duenas-Decamp MJ, Sullivan WM, Brown R, Ankghuambom C, Luzuriaga K, Robinson J, Burton DR, Bell J, Simmonds P, Ball J, Clapham PR. Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors. Retrovirology. 5: 5. PMID 18205925 DOI: 10.1186/1742-4690-5-5  0.01
2008 Menendez A, Calarese DA, Stanfield RL, Chow KC, Scanlan CN, Kunert R, Katinger H, Burton DR, Wilson IA, Scott JK. A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 1380-92. PMID 18198210 DOI: 10.1096/Fj.07-8983Com  1
2008 Bell CH, Pantophlet R, Schiefner A, Cavacini LA, Stanfield RL, Burton DR, Wilson IA. Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization. Journal of Molecular Biology. 375: 969-78. PMID 18068724 DOI: 10.1016/J.Jmb.2007.11.013  1
2008 Law M, Maruyama T, Lewis J, Giang E, Tarr AW, Stamataki Z, Gastaminza P, Chisari FV, Jones IM, Fox RI, Ball JK, McKeating JA, Kneteman NM, Burton DR. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nature Medicine. 14: 25-7. PMID 18064037 DOI: 10.1038/Nm1698  1
2008 Lee J, Fusco M, Hessell A, Oswald W, Burton D, Saphire E. Structure of the trimeric prefusionEbolavirus GP complexed with an antibody from a human survivor Acta Crystallographica Section a Foundations of Crystallography. 64: C58-C58. DOI: 10.1107/S0108767308098152  0.01
2008 Kneteman N, Law M, Maruyama T, Lewis J, Giang E, Burton D. IN VIVO PROTECTION AGAINST HCV BY BROADLY NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES Transplantation. 86: 63. DOI: 10.1097/01.tp.0000332572.61687.de  0.01
2008 Nicolaou KC, Wu TR, Sarlah D, Shaw DM, Rowcliffe E, Burton DR. ChemInform Abstract: Total Synthesis, Revised Structure, and Biological Evaluation of Biyouyanagin A and Analogues Thereof. Cheminform. 39. DOI: 10.1002/chin.200850222  1
2007 Barbas CF, Burton DR, Scott JK, Silverman GJ. Quantitation of DNA and RNA. Csh Protocols. 2007: pdb.ip47. PMID 21356961 DOI: 10.1101/Pdb.Ip47  1
2007 Scherer EM, Zwick MB, Teyton L, Burton DR. Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity. Aids (London, England). 21: 2131-9. PMID 18090039 DOI: 10.1097/Qad.0B013E3282A4A632  1
2007 Zwick MB, Burton DR. HIV-1 neutralization: Mechanisms and relevance to vaccine design Current Hiv Research. 5: 608-624. PMID 18045117 DOI: 10.2174/157016207782418443  1
2007 Klasse PJ, Burton DR. Antibodies to West Nile virus: a double-edged sword. Cell Host & Microbe. 1: 87-9. PMID 18005685 DOI: 10.1016/J.CHOM.2007.04.001  0.01
2007 Burton DR, Wilson IA. Immunology: Square-dancing antibodies Science. 317: 1507-1508. PMID 17872431 DOI: 10.1126/Science.1148905  1
2007 Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, Marx PA, Burton DR. Fc receptor but not complement binding is important in antibody protection against HIV. Nature. 449: 101-4. PMID 17805298 DOI: 10.1038/nature06106  1
2007 Mantis NJ, Palaia J, Hessell AJ, Mehta S, Zhu Z, Corthésy B, Neutra MR, Burton DR, Janoff EN. Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region. Journal of Immunology (Baltimore, Md. : 1950). 179: 3144-52. PMID 17709529 DOI: 10.4049/Jimmunol.179.5.3144  1
2007 Scanlan CN, Ritchie GE, Baruah K, Crispin M, Harvey DJ, Singer BB, Lucka L, Wormald MR, Wentworth P, Zitzmann N, Rudd PM, Burton DR, Dwek RA. Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody. Journal of Molecular Biology. 372: 16-22. PMID 17631311 DOI: 10.1016/J.Jmb.2007.06.027  1
2007 Crooks ET, Moore PL, Franti M, Cayanan CS, Zhu P, Jiang P, de Vries RP, Wiley C, Zharkikh I, Schülke N, Roux KH, Montefiori DC, Burton DR, Binley JM. A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120. Virology. 366: 245-62. PMID 17580087 DOI: 10.1016/J.Virol.2007.04.033  1
2007 Williams JV, Chen Z, Cseke G, Wright DW, Keefer CJ, Tollefson SJ, Hessell A, Podsiad A, Shepherd BE, Sanna PP, Burton DR, Crowe JE, Williamson RA. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. Journal of Virology. 81: 8315-24. PMID 17522220 DOI: 10.1128/Jvi.00106-07  1
2007 Saphire EO, Montero M, Menendez A, van Houten NE, Irving MB, Pantophlet R, Zwick MB, Parren PW, Burton DR, Scott JK, Wilson IA. Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies. Journal of Molecular Biology. 369: 696-709. PMID 17445828 DOI: 10.1016/J.Jmb.2007.01.060  1
2007 Pantophlet R, Aguilar-Sino RO, Wrin T, Cavacini LA, Burton DR. Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis. Virology. 364: 441-53. PMID 17418361 DOI: 10.1016/J.VIROL.2007.03.007  0.04
2007 Dhillon AK, Donners H, Pantophlet R, Johnson WE, Decker JM, Shaw GM, Lee FH, Richman DD, Doms RW, Vanham G, Burton DR. Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors. Journal of Virology. 81: 6548-62. PMID 17409160 DOI: 10.1128/Jvi.02749-06  1
2007 Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, Xiang SH, Yang X, Zhang MY, Zwick MB, Arthos J, Burton DR, Dimitrov DS, Sodroski J, Wyatt R, Nabel GJ, et al. Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature. 445: 732-7. PMID 17301785 DOI: 10.1038/Nature05580  1
2007 Nelson JD, Brunel FM, Jensen R, Crooks ET, Cardoso RM, Wang M, Hessell A, Wilson IA, Binley JM, Dawson PE, Burton DR, Zwick MB. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10. Journal of Virology. 81: 4033-43. PMID 17287272 DOI: 10.1128/Jvi.02588-06  1
2007 Law M, Cardoso RM, Wilson IA, Burton DR. Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy. Journal of Virology. 81: 4272-85. PMID 17267498 DOI: 10.1128/Jvi.02536-06  1
2007 Bowley DR, Labrijn AF, Zwick MB, Burton DR. Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage Protein Engineering, Design and Selection. 20: 81-90. PMID 17242026 DOI: 10.1093/protein/gzl057  1
2007 Oswald WB, Geisbert TW, Davis KJ, Geisbert JB, Sullivan NJ, Jahrling PB, Parren PW, Burton DR. Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. Plos Pathogens. 3: e9. PMID 17238286 DOI: 10.1371/Journal.Ppat.0030009  1
2007 Cardoso RM, Brunel FM, Ferguson S, Zwick M, Burton DR, Dawson PE, Wilson IA. Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10. Journal of Molecular Biology. 365: 1533-44. PMID 17125793 DOI: 10.1016/J.Jmb.2006.10.088  1
2007 Binley JM, Ngo-Abdalla S, Moore P, Bobardt M, Chatterji U, Gallay P, Burton DR, Wilson IA, Elder JH, de Parseval A. Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120 Retrovirology. 4: 23. DOI: 10.1186/1742-4690-4-23  0.01
2006 Ahuja SK, Aiuti F, Berkhout B, Biberfeld P, Burton DR, Colizzi V, Deeks SG, Desrosiers RC, Dierich MP, Doms RW, Emerman M, Gallo RC, Girard M, Greene WC, Hoxie JA, et al. A plea for justice for jailed medical workers. Science (New York, N.Y.). 314: 924-5. PMID 17062652 DOI: 10.1126/Science.1136578  1
2006 Luginbühl B, Kanyo Z, Jones RM, Fletterick RJ, Prusiner SB, Cohen FE, Williamson RA, Burton DR, Plückthun A. Directed evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretation. Journal of Molecular Biology. 363: 75-97. PMID 16962610 DOI: 10.1016/J.Jmb.2006.07.027  1
2006 Burton DR, Dwek RA. Immunology. Sugar determines antibody activity. Science (New York, N.Y.). 313: 627-8. PMID 16888131 DOI: 10.1126/Science.1131712  1
2006 Binley JM, Ngo-Abdalla S, Moore P, Bobardt M, Chatterji U, Gallay P, Burton DR, Wilson IA, Elder JH, de Parseval A. Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120. Retrovirology. 3: 39. PMID 16817962 DOI: 10.1186/1742-4690-3-39  1
2006 Leclerc E, Serban H, Prusiner SB, Burton DR, Williamson RA. Copper induces conformational changes in the N-terminal part of cell-surface PrPC. Archives of Virology. 151: 2103-9. PMID 16791441 DOI: 10.1007/s00705-006-0804-1  1
2006 Burton DR. Structural biology: images from the surface of HIV. Nature. 441: 817-8. PMID 16778874 DOI: 10.1038/441817a  0.01
2006 Wilson NA, Reed J, Napoe GS, Piaskowski S, Szymanski A, Furlott J, Gonzalez EJ, Yant LJ, Maness NJ, May GE, Soma T, Reynolds MR, Rakasz E, Rudersdorf R, McDermott AB, ... ... Burton DR, et al. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. Journal of Virology. 80: 5875-85. PMID 16731926 DOI: 10.1128/Jvi.00171-06  1
2006 Pantophlet R, Burton DR. GP120: target for neutralizing HIV-1 antibodies. Annual Review of Immunology. 24: 739-69. PMID 16551265 DOI: 10.1146/ANNUREV.IMMUNOL.24.021605.090557  0.08
2006 Yuste E, Sanford HB, Carmody J, Bixby J, Little S, Zwick MB, Greenough T, Burton DR, Richman DD, Desrosiers RC, Johnson WE. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma. Journal of Virology. 80: 3030-41. PMID 16501112 DOI: 10.1128/Jvi.80.6.3030-3041.2006  1
2006 Moore PL, Crooks ET, Porter L, Zhu P, Cayanan CS, Grise H, Corcoran P, Zwick MB, Franti M, Morris L, Roux KH, Burton DR, Binley JM. Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. Journal of Virology. 80: 2515-28. PMID 16474158 DOI: 10.1128/Jvi.80.5.2515-2528.2006  1
2006 Brunel FM, Zwick MB, Cardoso RM, Nelson JD, Wilson IA, Burton DR, Dawson PE. Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody. Journal of Virology. 80: 1680-7. PMID 16439525 DOI: 10.1128/Jvi.80.4.1680-1687.2006  1
2006 Scanlan C, Calarese D, Lee HK, Blixt O, Wong CH, Wilson I, Burton D, Dwek R, Rudd P. Antibody recognition of a carbohydrate epitope: a template for HIV vaccine design. Advances in Experimental Medicine and Biology. 564: 7-8. PMID 16400800 DOI: 10.1007/0-387-25515-X_4  0.08
2006 Zhang MX, Bohlman MC, Itatani C, Burton DR, Parren PW, St Jeor SC, Kozel TR. Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice. Infection and Immunity. 74: 362-9. PMID 16368991 DOI: 10.1128/Iai.74.1.362-369.2006  1
2006 Koff WC, Johnson PR, Watkins DI, Burton DR, Lifson JD, Hasenkrug KJ, McDermott AB, Schultz A, Zamb TJ, Boyle R, Desrosiers RC. HIV vaccine design: insights from live attenuated SIV vaccines. Nature Immunology. 7: 19-23. PMID 16357854 DOI: 10.1038/Ni1296  1
2006 Venturini S, Allicotti G, Zhao Y, Simon R, Burton DR, Pinilla C, Poignard P. Identification of peptides from human pathogens able to cross-activate an HIV-1-gag-specific CD4+ T cell clone. European Journal of Immunology. 36: 27-36. PMID 16323241 DOI: 10.1002/EJI.200425767  0.01
2006 Zhou T, Xu L, Dey B, Hessell AJ, Majeed S, Van Ryk D, Xiang S, Yang X, Zhang M, Zwick MB, Arthos J, Burton DR, Dimitrov DS, Sodroski J, Wyatt R, et al. Retrovirology. 3: S22. DOI: 10.1186/1742-4690-3-S1-S22  0.01
2005 Zitzmann N, Block T, Methta A, Rudd P, Burton D, Wilson I, Platt F, Butters T, Dwek RA. Glycosylation: Disease targets and therapy Advances in Experimental Medicine and Biology. 564: 1-2. PMID 16400797 DOI: 10.1007/0-387-25515-X_1  1
2005 Burton DR, Stanfield RL, Wilson IA. Antibody vs. HIV in a clash of evolutionary titans. Proceedings of the National Academy of Sciences of the United States of America. 102: 14943-8. PMID 16219699 DOI: 10.1073/Pnas.0505126102  1
2005 Calarese DA, Lee HK, Huang CY, Best MD, Astronomo RD, Stanfield RL, Katinger H, Burton DR, Wong CH, Wilson IA. Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proceedings of the National Academy of Sciences of the United States of America. 102: 13372-7. PMID 16174734 DOI: 10.1073/Pnas.0505763102  1
2005 Selvarajah S, Puffer B, Pantophlet R, Law M, Doms RW, Burton DR. Comparing antigenicity and immunogenicity of engineered gp120. Journal of Virology. 79: 12148-63. PMID 16160142 DOI: 10.1128/Jvi.79.19.12148-12163.2005  1
2005 Lindenbach BD, Evans MJ, Syder AJ, Wölk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. Complete replication of hepatitis C virus in cell culture. Science (New York, N.Y.). 309: 623-6. PMID 15947137 DOI: 10.1126/Science.1114016  1
2005 Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV. Robust hepatitis C virus infection in vitro. Proceedings of the National Academy of Sciences of the United States of America. 102: 9294-9. PMID 15939869 DOI: 10.1073/Pnas.0503596102  1
2005 Koefoed K, Farnaes L, Wang M, Svejgaard A, Burton DR, Ditzel HJ. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs Journal of Immunological Methods. 297: 187-201. PMID 15777942 DOI: 10.1016/J.Jim.2004.12.008  1
2005 Cardoso RM, Zwick MB, Stanfield RL, Kunert R, Binley JM, Katinger H, Burton DR, Wilson IA. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity. 22: 163-73. PMID 15723805 DOI: 10.1016/J.Immuni.2004.12.011  1
2005 Wahl-Jensen V, Kurz SK, Hazelton PR, Schnittler HJ, Ströher U, Burton DR, Feldmann H. Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. Journal of Virology. 79: 2413-9. PMID 15681442 DOI: 10.1128/Jvi.79.4.2413-2419.2005  0.01
2005 Zwick MB, Jensen R, Church S, Wang M, Stiegler G, Kunert R, Katinger H, Burton DR. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. Journal of Virology. 79: 1252-61. PMID 15613352 DOI: 10.1128/JVI.79.2.1252-1261.2005  1
2005 Xu L, Du X, Zhang W, Tang S, Soong N, Zwick M, Burton D, Whalen R. 984. Directed Molecular Evolution Generates Novel HIV-1 Envelope Variants That Can Elicit Broadly Neutralizing Antibody Responses in Rabbits Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.528  1
2004 O'Connor DH, McDermott AB, Krebs KC, Dodds EJ, Miller JE, Gonzalez EJ, Jacoby TJ, Yant L, Piontkivska H, Pantophlet R, Burton DR, Rehrauer WM, Wilson N, Hughes AL, Watkins DI. A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation. Journal of Virology. 78: 14012-22. PMID 15564508 DOI: 10.1128/Jvi.78.24.14012-14022.2004  1
2004 Blixt O, Head S, Mondala T, Scanlan C, Huflejt ME, Alvarez R, Bryan MC, Fazio F, Calarese D, Stevens J, Razi N, Stevens DJ, Skehel JJ, van Die I, Burton DR, et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proceedings of the National Academy of Sciences of the United States of America. 101: 17033-8. PMID 15563589 DOI: 10.1073/Pnas.0407902101  1
2004 Binley JM, Wrin T, Korber B, Zwick MB, Wang M, Chappey C, Stiegler G, Kunert R, Zolla-Pazner S, Katinger H, Petropoulos CJ, Burton DR. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. Journal of Virology. 78: 13232-52. PMID 15542675 DOI: 10.1128/Jvi.78.23.13232-13252.2004  1
2004 Pantophlet R, Wilson IA, Burton DR. Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12. Protein Engineering, Design & Selection : Peds. 17: 749-58. PMID 15542540 DOI: 10.1093/Protein/Gzh085  0.32
2004 Zhang MY, Xiao X, Sidorov IA, Choudhry V, Cham F, Zhang PF, Bouma P, Zwick M, Choudhary A, Montefiori DC, Broder CC, Burton DR, Quinnan GV, Dimitrov DS. Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody. Journal of Virology. 78: 9233-42. PMID 15308718 DOI: 10.1128/Jvi.78.17.9233-9242.2004  1
2004 Moore JP, Burton DR. Urgently needed: a filter for the HIV-1 vaccine pipeline. Nature Medicine. 10: 769-71. PMID 15286768 DOI: 10.1038/nm0804-769  0.01
2004 Bryan MC, Fazio F, Lee HK, Huang CY, Chang A, Best MD, Calarese DA, Blixt O, Paulson JC, Burton D, Wilson IA, Wong CH. Covalent display of oligosaccharide arrays in microtiter plates. Journal of the American Chemical Society. 126: 8640-1. PMID 15250702 DOI: 10.1021/Ja048433F  1
2004 Moroncini G, Kanu N, Solforosi L, Abalos G, Telling GC, Head M, Ironside J, Brockes JP, Burton DR, Williamson RA. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc. Proceedings of the National Academy of Sciences of the United States of America. 101: 10404-9. PMID 15240877 DOI: 10.1073/Pnas.0403522101  1
2004 Maruyama T, Saito I, Hayashi Y, Kompfner E, Fox RI, Burton DR, Ditzel HJ. Molecular analysis of the human autoantibody response to alpha-fodrin in Sjögren's syndrome reveals novel apoptosis-induced specificity. The American Journal of Pathology. 165: 53-61. PMID 15215161 DOI: 10.1016/S0002-9440(10)63274-9  0.01
2004 Woof JM, Burton DR. Human antibody-Fc receptor interactions illuminated by crystal structures. Nature Reviews. Immunology. 4: 89-99. PMID 15040582 DOI: 10.1038/nri1266  0.01
2004 Zwick MB, Komori HK, Stanfield RL, Church S, Wang M, Parren PW, Kunert R, Katinger H, Wilson IA, Burton DR. The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5. Journal of Virology. 78: 3155-61. PMID 14990736 DOI: 10.1128/Jvi.78.6.3155-3161.2004  1
2004 Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP, Nabel GJ, Sodroski J, Wilson IA, Wyatt RT. HIV vaccine design and the neutralizing antibody problem. Nature Immunology. 5: 233-6. PMID 14985706 DOI: 10.1038/Ni0304-233  1
2004 Biorn AC, Cocklin S, Madani N, Si Z, Ivanovic T, Samanen J, Van Ryk DI, Pantophlet R, Burton DR, Freire E, Sodroski J, Chaiken IM. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions. Biochemistry. 43: 1928-38. PMID 14967033 DOI: 10.1021/Bi035088I  1
2004 Lee HK, Scanlan CN, Huang CY, Chang AY, Calarese DA, Dwek RA, Rudd PM, Burton DR, Wilson IA, Wong CH. Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody. Angewandte Chemie (International Ed. in English). 43: 1000-3. PMID 14966891 DOI: 10.1002/Anie.200353105  1
2004 Darbha R, Phogat S, Labrijn AF, Shu Y, Gu Y, Andrykovitch M, Zhang MY, Pantophlet R, Martin L, Vita C, Burton DR, Dimitrov DS, Ji X. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope. Biochemistry. 43: 1410-7. PMID 14769016 DOI: 10.1021/BI035323X  0.04
2004 Zwick MB, Saphire EO, Burton DR. gp41: HIV's shy protein. Nature Medicine. 10: 133-4. PMID 14760422 DOI: 10.1038/Nm0204-133  1
2004 Burton DR, Desrosiers RC, Doms RW, Feinberg MB, Gallo RC, Hahn B, Hoxie JA, Hunter E, Korber B, Landay A, Lederman MM, Lieberman J, McCune JM, Moore JP, Nathanson N, et al. Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science (New York, N.Y.). 303: 316. PMID 14726576 DOI: 10.1126/Science.1094620  1
2004 Pantophlet R, Burton DR. Immunofocusing: antigen engineering to promote the induction of HIV-neutralizing antibodies. Trends in Molecular Medicine. 9: 468-73. PMID 14604823 DOI: 10.1016/J.MOLMED.2003.09.001  0.04
2004 Lee H, Scanlan CN, Huang C, Chang AY, Calarese DA, Dwek RA, Rudd PM, Burton DR, Wilson IA, Wong C. Reactivity-Based One-Pot Synthesis of Oligomannoses: Defining Antigens Recognized by 2G12, a Broadly Neutralizing anti-HIV-1 Antibody. Cheminform. 35. DOI: 10.1002/CHIN.200418206  0.01
2003 Scanlan CN, Pantophlet R, Wormald MR, Saphire EO, Calarese D, Stanfield R, Wilson IA, Katinger H, Dwek RA, Burton DR, Rudd PM. The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12. Advances in Experimental Medicine and Biology. 535: 205-18. PMID 14714897 DOI: 10.1007/978-1-4615-0065-0_13  1
2003 Saphire EO, Stanfield RL, Crispin MD, Morris G, Zwick MB, Pantophlet RA, Parren PW, Rudd PM, Dwek RA, Burton DR, Wilson IA. Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine design. Advances in Experimental Medicine and Biology. 535: 55-66. PMID 14714888 DOI: 10.1007/978-1-4615-0065-0_4  1
2003 Labrijn AF, Poignard P, Raja A, Zwick MB, Delgado K, Franti M, Binley J, Vivona V, Grundner C, Huang CC, Venturi M, Petropoulos CJ, Wrin T, Dimitrov DS, Robinson J, ... ... Burton DR, et al. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1. Journal of Virology. 77: 10557-65. PMID 12970440 DOI: 10.1128/Jvi.77.19.10557-10565.2003  1
2003 Mascola JR, Lewis MG, VanCott TC, Stiegler G, Katinger H, Seaman M, Beaudry K, Barouch DH, Korioth-Schmitz B, Krivulka G, Sambor A, Welcher B, Douek DC, Montefiori DC, Shiver JW, ... ... Burton DR, et al. Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies. Journal of Virology. 77: 10348-56. PMID 12970419 DOI: 10.1128/JVI.77.19.10348-10356.2003  1
2003 Johnson WE, Sanford H, Schwall L, Burton DR, Parren PW, Robinson JE, Desrosiers RC. Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities. Journal of Virology. 77: 9993-10003. PMID 12941910 DOI: 10.1128/Jvi.77.18.9993-10003.2003  1
2003 Peters PJ, Mironov A, Peretz D, van Donselaar E, Leclerc E, Erpel S, DeArmond SJ, Burton DR, Williamson RA, Vey M, Prusiner SB. Trafficking of prion proteins through a caveolae-mediated endosomal pathway. The Journal of Cell Biology. 162: 703-17. PMID 12925711 DOI: 10.1083/jcb.200304140  1
2003 Mironov A, Latawiec D, Wille H, Bouzamondo-Bernstein E, Legname G, Williamson RA, Burton D, DeArmond SJ, Prusiner SB, Peters PJ. Cytosolic prion protein in neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 7183-93. PMID 12904479 DOI: 10.1523/Jneurosci.23-18-07183.2003  1
2003 Choe H, Li W, Wright PL, Vasilieva N, Venturi M, Huang CC, Grundner C, Dorfman T, Zwick MB, Wang L, Rosenberg ES, Kwong PD, Burton DR, Robinson JE, Sodroski JG, et al. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell. 114: 161-70. PMID 12887918 DOI: 10.1016/S0092-8674(03)00508-7  1
2003 O'Connor DH, Mothe BR, Weinfurter JT, Fuenger S, Rehrauer WM, Jing P, Rudersdorf RR, Liebl ME, Krebs K, Vasquez J, Dodds E, Loffredo J, Martin S, McDermott AB, Allen TM, ... ... Burton DR, et al. Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses. Journal of Virology. 77: 9029-40. PMID 12885919 DOI: 10.1128/Jvi.77.16.9029-9040.2003  1
2003 Calarese DA, Scanlan CN, Zwick MB, Deechongkit S, Mimura Y, Kunert R, Zhu P, Wormald MR, Stanfield RL, Roux KH, Kelly JW, Rudd PM, Dwek RA, Katinger H, Burton DR, et al. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science (New York, N.Y.). 300: 2065-71. PMID 12829775 DOI: 10.1126/Science.1083182  1
2003 Zwick MB, Kelleher R, Jensen R, Labrijn AF, Wang M, Quinnan GV, Parren PW, Burton DR. A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12. Journal of Virology. 77: 6965-78. PMID 12768015 DOI: 10.1128/Jvi.77.12.6965-6978.2003  1
2003 Pantophlet R, Wilson IA, Burton DR. Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design. Journal of Virology. 77: 5889-901. PMID 12719582 DOI: 10.1128/Jvi.77.10.5889-5901.2003  0.2
2003 Zwick MB, Parren PW, Saphire EO, Church S, Wang M, Scott JK, Dawson PE, Wilson IA, Burton DR. Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120. Journal of Virology. 77: 5863-76. PMID 12719580 DOI: 10.1128/Jvi.77.10.5863-5876.2003  1
2003 Binley JM, Cayanan CS, Wiley C, Schülke N, Olson WC, Burton DR. Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions Journal of Virology. 77: 5678-5684. PMID 12719560 DOI: 10.1128/JVI.77.10.5678-5684.2003  1
2003 Veazey RS, Shattock RJ, Pope M, Kirijan JC, Jones J, Hu Q, Ketas T, Marx PA, Klasse PJ, Burton DR, Moore JP. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nature Medicine. 9: 343-6. PMID 12579198 DOI: 10.1038/nm833  1
2003 Leclerc E, Peretz D, Ball H, Solforosi L, Legname G, Safar J, Serban A, Prusiner SB, Burton DR, Williamson RA. Conformation of PrP(C) on the cell surface as probed by antibodies. Journal of Molecular Biology. 326: 475-83. PMID 12559915 DOI: 10.1016/S0022-2836(02)01365-7  1
2003 Herrera C, Spenlehauer C, Fung MS, Burton DR, Beddows S, Moore JP. Nonneutralizing antibodies to the CD4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site. Journal of Virology. 77: 1084-91. PMID 12502824 DOI: 10.1128/JVI.77.2.1084-1091.2003  1
2003 Pantophlet R, Ollmann Saphire E, Poignard P, Parren PW, Wilson IA, Burton DR. Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. Journal of Virology. 77: 642-58. PMID 12477867 DOI: 10.1128/Jvi.77.1.642-658.2003  0.12
2003 Poignard P, Moulard M, Golez E, Vivona V, Franti M, Venturini S, Wang M, Parren PW, Burton DR. Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies. Journal of Virology. 77: 353-65. PMID 12477840 DOI: 10.1128/JVI.77.1.353-365.2003  0.01
2002 Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S, Steenbeke TD, Venturi M, Chaiken I, Fung M, Katinger H, Parren PWIH, Robinson J, Van Ryk D, Wang L, ... Burton DR, et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites Nature. 420: 678-682. PMID 12478295 DOI: 10.1038/Nature01188  1
2002 Matsuoka T, Okamoto Y, Matsuzaki Z, Endo S, Ito E, Tsutsumi H, Williamson RA, Sakurai H, Burton DR, Saito I. Characteristics of immunity induced by viral antigen or conferred by antibody via different administration routes. Clinical and Experimental Immunology. 130: 386-92. PMID 12452827 DOI: 10.1046/j.1365-2249.2002.02003.x  1
2002 Safar JG, Scott M, Monaghan J, Deering C, Didorenko S, Vergara J, Ball H, Legname G, Leclerc E, Solforosi L, Serban H, Groth D, Burton DR, Prusiner SB, Williamson RA. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nature Biotechnology. 20: 1147-50. PMID 12389035 DOI: 10.1038/nbt748  1
2002 Meissner F, Maruyama T, Frentsch M, Hessell AJ, Rodriguez LL, Geisbert TW, Jahrling PB, Burton DR, Parren PWHI. Detection of antibodies against the four subtypes of ebola virus in Sera from any species using a novel antibody-phage indicator assay Virology. 300: 236-243. PMID 12350354 DOI: 10.1006/Viro.2002.1533  1
2002 Burton DR. Antibodies, viruses and vaccines. Nature Reviews. Immunology. 2: 706-13. PMID 12209139 DOI: 10.1038/nri891  0.04
2002 Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, Burton DR, DeArmond SJ, Prusiner SB, Scott MR. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron. 34: 921-32. PMID 12086640 DOI: 10.1016/S0896-6273(02)00726-2  1
2002 Scanlan CN, Pantophlet R, Wormald MR, Ollmann Saphire E, Stanfield R, Wilson IA, Katinger H, Dwek RA, Rudd PM, Burton DR. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. Journal of Virology. 76: 7306-21. PMID 12072529 DOI: 10.1128/Jvi.76.14.7306-7321.2002  1
2002 Venturini S, Mosier DE, Burton DR, Poignard P. Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization. Journal of Virology. 76: 6987-99. PMID 12072499 DOI: 10.1128/JVI.76.14.6987-6999.2002  0.04
2002 Saphire EO, Stanfield RL, Crispin MD, Parren PW, Rudd PM, Dwek RA, Burton DR, Wilson IA. Contrasting IgG structures reveal extreme asymmetry and flexibility. Journal of Molecular Biology. 319: 9-18. PMID 12051932 DOI: 10.1016/S0022-2836(02)00244-9  1
2002 Parren PWHI, Geisbert TW, Maruyama T, Jahrling PB, Burton DR. Pre- and postexposure prophylaxis of ebola virus infection in an animal model by passive transfer of a neutralizing human antibody Journal of Virology. 76: 6408-6412. PMID 12021376 DOI: 10.1128/Jvi.76.12.6408-6412.2002  1
2002 Moulard M, Phogat SK, Shu Y, Labrijn AF, Xiao X, Binley JM, Zhang MY, Sidorov IA, Broder CC, Robinson J, Parren PW, Burton DR, Dimitrov DS. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes. Proceedings of the National Academy of Sciences of the United States of America. 99: 6913-8. PMID 11997472 DOI: 10.1073/pnas.102562599  1
2002 Binley JM, Sanders RW, Master A, Cayanan CS, Wiley CL, Schiffner L, Travis B, Kuhmann S, Burton DR, Hu SL, Olson WC, Moore JP. Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. Journal of Virology. 76: 2606-16. PMID 11861826 DOI: 10.1128/JVI.76.6.2606-2616.2002  1
2002 De Carvalho Nicacio C, Williamson AR, Parren PWHI, Lundkvist A, Burton DR, Björling E. Neutralizing human Fab fragments against measles virus recovered by phage display Journal of Virology. 76: 251-258. PMID 11739690 DOI: 10.1128/JVI.76.1.251-258.2002  1
2001 Zwick MB, Wang M, Poignard P, Stiegler G, Katinger H, Burton DR, Parren PWHI. Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies Journal of Virology. 75: 12198-12208. PMID 11711611 DOI: 10.1128/JVI.75.24.12198-12208.2001  1
2001 Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, Binley JM, Moore JP, Stiegler G, Katinger H, Burton DR, Parren PW. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. Journal of Virology. 75: 10892-905. PMID 11602729 DOI: 10.1128/Jvi.75.22.10892-10905.2001  1
2001 Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G, Mehlhorn IR, Legname G, Wormald MR, Rudd PM, Dwek RA, Burton DR, Prusiner SB. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature. 412: 739-43. PMID 11507642 DOI: 10.1038/35089090  1
2001 Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, Rudd PM, Dwek RA, Stanfield RL, Burton DR, Wilson IA. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science (New York, N.Y.). 293: 1155-9. PMID 11498595 DOI: 10.1126/Science.1061692  1
2001 Parren PW, Marx PA, Hessell AJ, Luckay A, Harouse J, Cheng-Mayer C, Moore JP, Burton DR. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. Journal of Virology. 75: 8340-7. PMID 11483779 DOI: 10.1128/JVI.75.17.8340-8347.2001  0.01
2001 Schaller M, Burton DR, Ditzel HJ. Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nature Immunology. 2: 746-53. PMID 11477412 DOI: 10.1038/90696  0.01
2001 Zwick MB, Bonnycastle LL, Menendez A, Irving MB, Barbas CF, Parren PW, Burton DR, Scott JK. Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12. Journal of Virology. 75: 6692-9. PMID 11413337 DOI: 10.1128/Jvi.75.14.6692-6699.2001  1
2001 Matsunaga Y, Peretz D, Williamson A, Burton D, Mehlhorn I, Groth D, Cohen FE, Prusiner SB, Baldwin MA. Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: dependence of conformation on pH. Proteins. 44: 110-8. PMID 11391773 DOI: 10.1002/Prot.1077  1
2001 Moore JP, Parren PW, Burton DR. Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development. Journal of Virology. 75: 5721-9. PMID 11390574 DOI: 10.1128/JVI.75.13.5721-5729.2001  0.01
2001 Bugli F, Bastidas R, Burton DR, Williamson RA, Clementi M, Burioni R. Molecular profile of a human monoclonal antibody Fab fragment specific for Epstein-Barr virus gp350/220 antigen. Human Immunology. 62: 362-7. PMID 11295468 DOI: 10.1016/S0198-8859(01)00216-6  0.01
2001 Parren PW, Burton DR. The antiviral activity of antibodies in vitro and in vivo. Advances in Immunology. 77: 195-262. PMID 11293117 DOI: 10.1016/S0065-2776(01)77018-6  0.01
2001 Leclerc E, Peretz D, Ball H, Sakurai H, Legname G, Serban A, Prusiner SB, Burton DR, Williamson RA. Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form. The Embo Journal. 20: 1547-54. PMID 11285219 DOI: 10.1093/emboj/20.7.1547  1
2001 Peretz D, Scott MR, Groth D, Williamson RA, Burton DR, Cohen FE, Prusiner SB. Strain-specified relative conformational stability of the scrapie prion protein. Protein Science : a Publication of the Protein Society. 10: 854-63. PMID 11274476 DOI: 10.1110/ps.39201  1
2001 Poignard P, Saphire EO, Parren PW, Burton DR. gp120: Biologic aspects of structural features. Annual Review of Immunology. 19: 253-74. PMID 11244037 DOI: 10.1146/Annurev.Immunol.19.1.253  1
2001 Gilden DH, Burgoon MP, Kleinschmidt-DeMasters BK, Williamson RA, Ghausi O, Burton DR, Owens GP. Molecular immunologic strategies to identify antigens and b-cell responses unique to multiple sclerosis. Archives of Neurology. 58: 43-8. PMID 11176935 DOI: 10.1001/Archneur.58.1.43  1
2001 Williamson RA, Burgoon MP, Owens GP, Ghausi O, Leclerc E, Firme L, Carlson S, Corboy J, Parren PW, Sanna PP, Gilden DH, Burton DR. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 98: 1793-8. PMID 11172030 DOI: 10.1073/Pnas.98.4.1793  1
2001 Saphire EO, Parren PW, Barbas CF, Burton DR, Wilson IA. Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: an antibody that broadly neutralizes primary isolates of HIV-1. Acta Crystallographica. Section D, Biological Crystallography. 57: 168-71. PMID 11134947 DOI: 10.1107/S0907444900017376  1
2001 Burton DR. An unfinished quest Nature. 414: 251-252. DOI: 10.1038/35104670  0.01
2000 Burton DR, Parren PW. Fighting the Ebola virus. Nature. 408: 527-8. PMID 11117724 DOI: 10.1038/35046176  0.01
2000 Wong BS, Vénien-Bryan C, Williamson RA, Burton DR, Gambetti P, Sy MS, Brown DR, Jones IM. Copper refolding of prion protein. Biochemical and Biophysical Research Communications. 276: 1217-24. PMID 11027613 DOI: 10.1006/BBRC.2000.3604  0.01
2000 Sanna PP, Burton DR. Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts. Journal of Virology. 74: 9813-7. PMID 11024107 DOI: 10.1128/JVI.74.21.9813-9817.2000  0.01
2000 Ditzel HJ, Masaki Y, Nielsen H, Farnaes L, Burton DR. Cloning and expression of a novel human antibody-antigen pair associated with Felty's syndrome Proceedings of the National Academy of Sciences of the United States of America. 97: 9234-9239. PMID 10922075 DOI: 10.1073/Pnas.97.16.9234  1
2000 Dorrell L, Hessell AJ, Wang M, Whittle H, Sabally S, Rowland-Jones S, Burton DR, Parren PW. Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia. Aids (London, England). 14: 1117-22. PMID 10894275 DOI: 10.1097/00002030-200006160-00008  0.01
2000 Parren PW, Poignard P, Ditzel HJ, Williamson RA, Burton DR. Antibodies in human infectious disease. Immunologic Research. 21: 265-78. PMID 10852127 DOI: 10.1385/IR:21:2-3:265  0.04
2000 Wong BS, Clive C, Haswell SJ, Williamson RA, Burton DR, Gambetti P, Sy MS, Jones IM, Brown DR. Copper has differential effect on prion protein with polymorphism of position 129. Biochemical and Biophysical Research Communications. 269: 726-31. PMID 10720484 DOI: 10.1006/BBRC.2000.2355  0.01
2000 Burton DR, Parren PW. Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection? Nature Medicine. 6: 123-5. PMID 10655088 DOI: 10.1038/72200  0.01
2000 Wang H, Griffiths MN, Burton DR, Ghazal P. Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization. Proceedings of the National Academy of Sciences of the United States of America. 97: 847-52. PMID 10639168 DOI: 10.1073/PNAS.97.2.847  0.01
2000 Owens GP, Williamson RA, Burgoon MP, Ghausi O, Burton DR, Gilden DH. Cloning the antibody response in humans with chronic inflammatory disease: immunopanning of subacute sclerosing panencephalitis (SSPE) brain sections with antibody phage libraries prepared from SSPE brain enriches for antibody recognizing measles virus antigens in situ. Journal of Virology. 74: 1533-7. PMID 10627565 DOI: 10.1128/Jvi.74.3.1533-1537.2000  1
2000 Wong B, Brown DR, Clive C, Haswell S, Sy M, Gambetti P, Williamson RA, Burton DR, Jones IM. Effect of copper on recombinant mouse prion protein Biochemical Society Transactions. 28: A36-A36. DOI: 10.1042/Bst028A036B  0.01
2000 Wong B, Clive C, Haswell SJ, Jones IM, Brown DR. Copper Has Differential Effect on Prion Protein with Polymorphism of Position 129 Biochemical and Biophysical Research Communications. 271: 842. DOI: 10.1006/BBRC.2000.2642  0.01
1999 Kanyo ZF, Pan KM, Williamson RA, Burton DR, Prusiner SB, Fletterick RJ, Cohen FE. Antibody binding defines a structure for an epitope that participates in the PrPC-->PrPSc conformational change. Journal of Molecular Biology. 293: 855-63. PMID 10543972 DOI: 10.1006/Jmbi.1999.3193  1
1999 Maruyama T, Rodriguez LL, Jahrling PB, Sanchez A, Khan AS, Nichol ST, Peters CJ, Parren PW, Burton DR. Ebola virus can be effectively neutralized by antibody produced in natural human infection. Journal of Virology. 73: 6024-30. PMID 10364354 DOI: 10.1128/JVI.73.7.6024-6030.1999  1
1999 Sanna PP, Samson ME, Moon JS, Rozenshteyn R, De Logu A, Williamson RA, Burton DR. pFab-CMV, a single vector system for the rapid conversion of recombinant Fabs into whole IgG1 antibodies. Immunotechnology : An International Journal of Immunological Engineering. 4: 185-8. PMID 10231088 DOI: 10.1016/S1380-2933(98)00022-0  0.01
1999 Poignard P, Sabbe R, Picchio GR, Wang M, Gulizia RJ, Katinger H, Parren PW, Mosier DE, Burton DR. Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity. 10: 431-8. PMID 10229186 DOI: 10.1016/S1074-7613(00)80043-6  0.01
1999 Sakurai H, Williamson RA, Crowe JE, Beeler JA, Poignard P, Bastidas RB, Chanock RM, Burton DR. Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines. Journal of Virology. 73: 2956-62. PMID 10074145 DOI: 10.1128/JVI.73.4.2956-2962.1999  1
1999 Maruyama T, Parren PW, Sanchez A, Rensink I, Rodriguez LL, Khan AS, Peters CJ, Burton DR. Recombinant human monoclonal antibodies to Ebola virus. The Journal of Infectious Diseases. 179: S235-9. PMID 9988189 DOI: 10.1086/514280  1
1999 Moore JP, Burton DR. HIV-1 neutralizing antibodies: how full is the bottle? Nature Medicine. 5: 142-4. PMID 9930854 DOI: 10.1038/5502  0.01
1999 Crawford JM, Earl PL, Moss B, Reimann KA, Wyand MS, Manson KH, Bilska M, Zhou JT, Pauza CD, Parren PWHI, Burton DR, Sodroski JG, Letvin NL, Montefiori DC. Characterization of Primary Isolate-Like Variants of Simian-Human Immunodeficiency Virus Journal of Virology. 73: 10199-10207. DOI: 10.1128/jvi.73.12.10199-10207.1999  0.01
1998 Crowe JE, Firestone CY, Crim R, Beeler JA, Coelingh KL, Barbas CF, Burton DR, Chanock RM, Murphy BR. Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein. Virology. 252: 373-5. PMID 9878616 DOI: 10.1006/Viro.1998.9462  1
1998 Parren PW, Wang M, Trkola A, Binley JM, Purtscher M, Katinger H, Moore JP, Burton DR. Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1. Journal of Virology. 72: 10270-4. PMID 9811774 DOI: 10.1128/JVI.72.12.10270-10274.1998  0.01
1998 Williamson RA, Peretz D, Pinilla C, Ball H, Bastidas RB, Rozenshteyn R, Houghten RA, Prusiner SB, Burton DR. Mapping the prion protein using recombinant antibodies. Journal of Virology. 72: 9413-8. PMID 9765500 DOI: 10.1128/JVI.72.11.9413-9418.1998  1
1998 Graus YF, de Baets MH, Burton DR. Antiacetylcholine receptor Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. Annals of the New York Academy of Sciences. 841: 414-7. PMID 9668268 DOI: 10.1111/J.1749-6632.1998.TB10956.X  0.01
1998 Agosto M, Allan J, Benson C, Berger EA, Blumenthal R, Burton D, Clements J, Coffin J, Connor R, Cullen B, Desrosiers R, Dimitrov D, Doms R, Emerman M, Feinberg M, et al. AIDS vaccine development. Science (New York, N.Y.). 280: 803, 804-5. PMID 9599148 DOI: 10.1126/Science.280.5365.803C  0.01
1998 Burton DR, Moore JP. Why do we not have an HIV vaccine and how can we make one? . Nature Medicine. 4: 495-8. PMID 9585194 DOI: 10.1038/NM0598SUPP-495  0.01
1998 Salonen EM, Parren PW, Graus YF, Lundkvist A, Fisicaro P, Vapalahti O, Kallio-Kokko H, Vaheri A, Burton DR. Human recombinant Puumala virus antibodies: cross-reaction with other hantaviruses and use in diagnostics. The Journal of General Virology. 659-65. PMID 9568958 DOI: 10.1099/0022-1317-79-4-659  0.01
1998 Ditzel HJ, Rosenkilde MM, Garred P, Wang M, Koefoed K, Pedersen C, Burton DR, Schwartz TW. The CCR5 receptor acts as an alloantigen in CCR5Delta32 homozygous individuals: identification of chemokineand HIV-1-blocking human antibodies. Proceedings of the National Academy of Sciences of the United States of America. 95: 5241-5. PMID 9560260 DOI: 10.1073/PNAS.95.9.5241  0.01
1998 LeBlanc JF, McLane KE, Parren PW, Burton DR, Ghazal P. Recognition properties of a sequence-specific DNA binding antibody. Biochemistry. 37: 6015-22. PMID 9558339 DOI: 10.1021/BI9730792  0.01
1998 Parren PW, Mondor I, Naniche D, Ditzel HJ, Klasse PJ, Burton DR, Sattentau QJ. Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity. Journal of Virology. 72: 3512-9. PMID 9557629 DOI: 10.1128/JVI.72.5.3512-3519.1998  0.01
1998 Glamann J, Burton DR, Parren PWHI, Ditzel HJ, Kent KA, Arnold C, Montefiori D, Hirsch VM. Simian immunodeficiency virus (SIV) envelope-specific Fabs with high- level homologous neutralizing activity: Recovery from a long-term- nonprogressor SIV-infected macaque Journal of Virology. 72: 585-592. PMID 9420262 DOI: 10.1128/JVI.72.1.585-592.1998  1
1998 Gauduin MC, Parren PW, Weir R, Barbas CF, Burton DR, Koup RA. Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1. Nature Medicine. 3: 1389-93. PMID 9396610 DOI: 10.1038/NM1297-1389  0.04
1998 Burton DR. Phage display. Immunotechnology : An International Journal of Immunological Engineering. 1: 87-94. PMID 9373337 DOI: 10.1016/1380-2933(95)00013-5  0.04
1998 Moreno de Alborán I, Martínéz-alonso C, Barbas CF, Burton DR, Ditzel HJ. Human monoclonal Fab fragments specific for viral antigens from combinatorial IgA libraries. Immunotechnology : An International Journal of Immunological Engineering. 1: 21-8. PMID 9373330 DOI: 10.1016/1380-2933(95)00002-X  0.01
1998 Sullivan N, Sun Y, Binley J, Lee J, Barbas CF, Parren PWHI, Burton DR, Sodroski J. Determinants of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Activation by Soluble CD4 and Monoclonal Antibodies Journal of Virology. 72: 6332-6338. DOI: 10.1128/jvi.72.8.6332-6338.1998  0.01
1998 Frankel SS, Steinman RM, Michael NL, Kim SR, Bhardwaj N, Pope M, Louder MK, Ehrenberg PK, Parren PWHI, Burton DR, Katinger H, VanCott TC, Robb ML, Birx DL, Mascola JR. Neutralizing Monoclonal Antibodies Block Human Immunodeficiency Virus Type 1 Infection of Dendritic Cells and Transmission to T Cells Journal of Virology. 72: 9788-9794. DOI: 10.1128/jvi.72.12.9788-9794.1998  0.01
1998 Maruyama T. Ebola Virus, Neutrophils, and Antibody Specificity Science. 282: 843a-843. DOI: 10.1126/Science.282.5390.843A  0.01
1998 Burton D, Tainer J. Protein engineering structure and design, prediction and evolution: cycling to success Current Opinion in Biotechnology. 9: 335-337. DOI: 10.1016/S0958-1669(98)80003-7  0.01
1997 Peretz D, Williamson RA, Matsunaga Y, Serban H, Pinilla C, Bastidas RB, Rozenshteyn R, James TL, Houghten RA, Cohen FE, Prusiner SB, Burton DR. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. Journal of Molecular Biology. 273: 614-22. PMID 9356250 DOI: 10.1006/jmbi.1997.1328  1
1997 Burton DR. A vaccine for HIV type 1: the antibody perspective. Proceedings of the National Academy of Sciences of the United States of America. 94: 10018-23. PMID 9294155 DOI: 10.1073/PNAS.94.19.10018  0.01
1997 Parren PW, Gauduin MC, Koup RA, Poignard P, Sattentau QJ, Fisicaro P, Burton DR. Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design". Immunology Letters. 58: 125-32. PMID 9271324 DOI: 10.1016/S0165-2478(97)00109-0  0.01
1997 Mo H, Stamatatos L, Ip JE, Barbas CF, Parren PW, Burton DR, Moore JP, Ho DD. Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off. Journal of Virology. 71: 6869-74. PMID 9261412 DOI: 10.1128/Jvi.71.9.6869-6874.1997  0.01
1997 Parren PW, Gauduin MC, Koup RA, Poignard P, Fisicaro P, Burton DR, Sattentau QJ. Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design. Immunology Letters. 57: 105-12. PMID 9232434 DOI: 10.1016/S0165-2478(97)00043-6  0.01
1997 Graus YF, de Baets MH, van Breda Vriesman PJ, Burton DR. Anti-acetylcholine receptor Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. Immunology Letters. 57: 59-62. PMID 9232426 DOI: 10.1016/S0165-2478(97)00046-1  0.01
1997 Williamson RA, Lazzarotto T, Sanna PP, Bastidas RB, Dalla Casa B, Campisi G, Burioni R, Landini MP, Burton DR. Use of recombinant human antibody fragments for detection of cytomegalovirus antigenemia. Journal of Clinical Microbiology. 35: 2047-50. PMID 9230379 DOI: 10.1128/jcm.35.8.2047-2050.1997  0.01
1997 Li AN, Baba TW, Sodroski J, Zolla-Pazner S, Gorny MK, Robinson J, Posner MR, Katinger H, Barbas CF, Burton DR, Chou TC, Ruprecht RM. Synergistic neutralization of a chimetic SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins Aids Research and Human Retroviruses. 13: 647-656. PMID 9168233 DOI: 10.1089/Aid.1997.13.647  1
1997 Cattani P, Rossolini GM, Cresti S, Santangelo R, Burton DR, Williamson RA, Sanna PP, Fadda G. Detection and typing of herpes simplex viruses by using recombinant immunoglobulin fragments produced in bacteria. Journal of Clinical Microbiology. 35: 1504-9. PMID 9163470 DOI: 10.1128/jcm.35.6.1504-1509.1997  0.01
1997 Kessler JA, McKenna PM, Emini EA, Chan CP, Patel MD, Gupta SK, Mark GE, Barbas CF, Burton DR, Conley AJ. Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates. Aids Research and Human Retroviruses. 13: 575-82. PMID 9135875  1
1997 Ditzel HJ, Parren PW, Binley JM, Sodroski J, Moore JP, Barbas CF, Burton DR. Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries. Journal of Molecular Biology. 267: 684-95. PMID 9126846 DOI: 10.1006/Jmbi.1997.0912  0.01
1997 Parren PW, Burton DR, Sattentau QJ. HIV-1 antibody--debris or virion? Nature Medicine. 3: 366-7. PMID 9095159 DOI: 10.1038/nm0497-366d  0.01
1997 Parren PW, Fisicaro P, Labrijn AF, Binley JM, Yang WP, Ditzel HJ, Barbas CF, Burton DR. In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope. Journal of Virology. 70: 9046-50. PMID 8971041 DOI: 10.1128/jvi.70.12.9046-9050.1996  0.01
1997 Parren PW, Sattenau QJ, Burton DR. Importance of anti-HIV-1 antibodies Nature Medicine. 3: 591-591. DOI: 10.1038/nm0697-591a  0.01
Show low-probability matches.